Studies on the mechanisms of RNA-driven DNA repair and modification by Shen, Ying
STUDIES ON THE MECHANISMS OF RNA-DRIVEN DNA REPAIR 



























In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in the 












     




























Approved by:   
   
Dr. Francesca Storici, Advisor 
School of Biology 
Georgia Institute of Technology 
 Dr. Yuhong Fan 
School of Biology 
Georgia Institute of Technology 
   
Dr. Kirill Lobachev 
School of Biology 
Georgia Institute of Technology 
 Dr. Anita Corbett 
Department of Biochemistry 
School of Medicine 
Emory University 
   
Dr. Yury Chernoff 
School of Biology 
Georgia Institute of Technology 
  
   






























First, I would like to thank my advisor Dr. Francesca Storici for her guidance, 
encouragement and support. It has been an honor to be her first Ph.D. student. She has 
taught me how good science is done. The passion she has for her research motivates me 
all the time in the Ph.D. pursuit. I appreciate all of her contributions of time, ideas, and 
funding to make my Ph.D. study productive. I am also thankful for the excellent example 
she has provided as a woman biologist and professor. 
 
I would like to thank all my committee members, Dr. Kirill Lobachev, Dr. Yury 
Chernoff, Dr. Yuhong Fan, and Dr. Anita Corbett for their guidance and feedback on my 
Ph.D. study. I would also like to thank our collaborator Dr. Bernard Weiss for his insight 
and advice for our collaboration projects. 
 
I would like to thank all the members of the Storici lab: Rekha Pai, Kuntal Mukherjee, 
Patrick Ruff, Samantha Stuckey, Kyung Duk Koh, Havva Keskin, as well as former and 
present undergraduate students and rotation students. Especially, I would like to 
acknowledge Kyung Duk Koh and Katie Ashley for their immense help for my 
experiments. I appreciate everyone for their effort to make our group full of friendship, 
good advice and great fun.  
 
Finally, I would like to thank my parents. Their love, encouragement and understanding 
have always support me through hard times in my life.  
 v 
TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES vii 
LIST OF FIGURES ix 
LIST OF SYMBOLS AND ABBREVIATIONS xi 
SUMMARY xiv 
CHAPTER 
1 Introduction 1 
1.1. Genome instability and DNA repair 1 
1.2. rNMPs can be incorporated into chromosomal DNA 2 
1.3. The role of RNases H in the degradation of RNA/DNA hybrids 4 
1.4. Mismatch repair 6 
1.5. Application of oligos in the studies of DNA repair and modification 9 
1.6. Research goals 17 
2 RNA-driven genetic changes in bacteria and human cells 19 
2.1. Abstract 20 
2.2. Introduction 21 
2.3. Materials and methods 24 
2.4. Results and discussion 29 
2.5. Conclusions 48 
2.6. Acknowledgements 50 
3 Generation of RNA/DNA hybrids in genomic DNA by transformation using 
RNA-containing oligonucleotides 51 
 vi 
3.1. Abstract 52 
3.2. Protocol 53 
3.3. Materials 60 
3.4. Representative results 63 
3.5. Discussion 68 
3.6. Acknowledgements 70 
4    Mispaired rNMPs in DNA are mutagenic and are targets of mismatch repair and 
RNases H 71 
                  4.1. Abstract 72 
                  4.2. Introduction 73 
                  4.3. Materials and methods 75 
                  4.4. Results 80 
                  4.5. Discussion 97 
                  4.6. Acknowledgements 102 
5    Conclusions 103 
6    Implications 107 
APPENDIX A: Supplementary materials of Chapter 4 112 
REFERENCES 131 
 vii 
LIST OF TABLES 
Page 
Table 2.1: DNA sequences of oligos used in this study and part of the GFP locus 
disrupted by the I-SceI site 28 
Table 2.2: Strand-bias targeting of RNA-containing oligos in E. coli 34 
Table 2.3: Alkali lability of RNA-containing oligos in E. coli 34 
Table 4.1: The effect of RNase HI (rnhA) and RNase HII (rnhB) mutations on 
transformation by rNMP-containing oligos in E. coli mutS cells 84 
Table 4.2: Tolerance of an rG/dT mispair in E. coli 90 
Table 4.3: Strong effect of RNase HII and minor effect of MutS in preventing gene 
correction by an rC/dA mispair in E. coli 92 
Table 4.4: Competition between mismatch repair and RNase H type 2 functions in the 
removal of RNA/DNA mispairs in yeast 96 
Table A.1: Bacterial and yeast strains used in this study 114 
Table A.2: Oligos used in this study 116 
Table A.3: Statistical comparisons (P-values) between gene correction frequencies 
obtained for different oligos in different genetic backgrounds 117 
Table A.4: Alkali lability of RNA-containing oligos used in E. coli or yeast 
transformation assays 125 
 viii 
Table A.5: Reversion frequency of a nonsense mutation or a two-base deletion in the 
yeast trp5 gene following transformation by rNMP-containing oligos in MMR 
and RNase H mutant cells 127 
Table A.6: Deletion and nonsense mutations of rnhA and rnhB genes similarly affect 
gene correction by oligos in the BW1988 and the BW2037 backgrounds 130 
 
 ix 
LIST OF FIGURES 
Page 
Figure 1.1: Scheme of rNMPs present in genomic DNA 3 
Figure 1.2: Scheme of the methyl-directed MMR in E. coli 8 
Figure 1.3: Scheme of the MMR in eukaryotes 9 
Figure 1.4: Scheme of oligo-directed DNA modification via the Lambda Red 
recombination system in E. coli 11 
Figure 1.5: Repair of a DSB by RNA-containing oligos 15 
Figure 1.6: Strand bias targeting of RNA-containing oligos and their complementary 
DNA-only oligos 16 
Figure 2.1: Scheme of the E. coli chromosomal region with the lacZ gene mutated and 
then repaired by the LacZ.R6 oligo or the LacZ.R6 comp oligo 33 
Figure 2.2: Chromosomal DNA modifications mediated by RNA-containing oligos in 
human cells 37 
Figure 2.3: Alkali lability of RNA-containing oligos in human cells 40 
Figure 2.4: Detection of GFP bands following PCR from genomic DNA of human green 
fluorescent cells targeted by the DNA-only oligo GFP.D or the RNA-
containing oligo GFP.R6 41 
Figure 2.5: Strand-bias targeting to broken chromosomal GFP in human cells 44 
 x 
Figure 2.6: Plasmid DNA modifications mediated by RNA-containing oligos in human 
cells 47 
Figure 3.1: Schematic diagram of the defective trp5 gene and of the TRP5 allele   
corrected by the RNA-containing oligo 63 
Figure 3.2: Transformation result with the RNA-containing oligo 64 
Figure 3.3: Detection of genetic information transfer from the RNA-containing oligo to    
yeast chromosomal DNA by restriction digestion of the PCR product amplifying 
the targeted genomic region                                                                               65 
Figure 3.4: DNA sequencing results showing gene correction by the RNA-containing 
oligo 66 
Figure 3.5: Alkali treatment prevents gene correction by the RNA-containing oligo 67 
Figure 4.1: Diagrams and sequences of the E. coli lacZ and rpsL loci and the yeast trp5 
locus targeted by the RNA-containing oligos 83 
Figure 4.2: RNase HII cleavage specificity 87 
Figure 6.1: Scheme of transcript RNA-mediated DSB repair 108 
Figure A.1: Denaturing polyacrylamide gel showing fragments resulting from RNase HII 
cleavage and random RNA degradation in the absence of RNase HII 112 
Figure A.2: Strand-bias targeting effect of two complementary oligos, Trp5.72D and 
TRP5.72Dcom is mild in wt and cannot be observed in msh2 mutant strains113 
 xi 
LIST OF SYMBOLS AND ABBREVIATIONS 
 
 
8-oxoG                                                                              8-hydroxyguanine  
AGS  Aicardi-Goutieres syndrome 
BER  base-excision repair 
bp  basepair 
BSA  bovine serum albumin 
cDNA  complementary DNA 
cm
3
  cubic centimeter 
CMV  cytomegalovirus 
DAM  deoxyadenine methylase 
DMEM  Dulbecco‟s modified Eagle‟s medium 
DNA  deoxyribonucleic acid 
dNMP  deoxyribonucleoside monophosphate 
dNTP  deoxyribonucleotide  
DSB  double-strand break 
dsDNA  double-stranded DNA 
dUMP  deoxyuridine monophosphate 
GFP  green fluorescent protein 
HEK  human embryonic kidney 
hr  hour 
IDL  insertion/deletion loop 
Ig  immunoglobulin 
JRNase  junction ribonuclease 
 xii 
kb  kilobase 
L  liter 
LINE                                                                                      long interspersed element 
M  molar 
MAT  mating type 
mg  milligram 
min  minute 
mL  milliliter 
mm
3
  cubic millimeter 
MMR  mismatch repair system 
mtDNA  mitochondrial DNA 
NER  nucleotide-excision repair 
nmole  nanomole 
nt  nucleotide 
O
6
-MeG                                                                              O
6
-Methylguanine 
OGG  8-oxoguanine DNA glycosylase 
oligo  oligonucleotide 
PAGE  polyacrylamide gel electrophoresis 
PCR  polymerase chain reaction 
PEI  polyethylenimine 
pmole  picomole 
pol  polymerase 
RNA  ribonucleic acid 
RNase H  ribonuclease H 
rNMP  ribonucleoside monophosphate 
 xiii 
rpm  round per minute 
RT  reverse-transcriptase 
rUMP  uridine monophosphate 
SC-Trp  synthetic complete medium without tryptophan 
sec  second 
ssDNA  single-stranded DNA 
TBE  Tris/Borate/EDTA 
Ty  Transposons of yeast 
UV  ultraviolet 
WT  wild-type 
L  microliter 
















Our previous studies have demonstrated that RNA can serve as a template for double-
strand break (DSB) repair in the yeast Saccharomyces cerevisiae using synthetic RNA-
containing oligonucleotides (oligos). Following this initial work, we show that the RNA 
tract of RNA-containing oligos can be copied into DNA to transfer a genetic change at 
the chromosomal level also in the bacterium Escherichia coli and in human cells. 
Exploiting the use of oligos containing ribonucleoside monophosphates (rNMPs), we 
developed a molecular approach to generate RNA/DNA hybrids of chosen sequence and 
structure at the chromosomal level in both yeast and E. coli cells. Such technique allows 
us to study how rNMPs present in the DNA genome of cells are tolerated by cells, what 
factors recognize and target rNMPs in DNA and to what extent the embedded rNMPs 
may alter genome integrity. Here we proved that mispaired rNMPs embedded into 
genomic DNA, if not removed, serve as templates for DNA synthesis during 
chromosomal replication and produce a genetic change. We discovered that mispaired 
rNMPs that are embedded in genomic DNA are not only targeted by ribonucleases H 
(RNases H) but also by the mismatch repair (MMR) system both in yeast and in E. coli. 
Our data reveal novel substrates for the MMR system, and also uncover an unpredicted 







1.1. Genome instability and DNA repair 
Genome integrity is under constant attack from numerous exogenous agents, including 
chemical agents, UV radiation, and ionizing radiation, and from endogenous sources, 
such as reactive oxygen species, endogenous alkylating agents, DNA single- and double- 
strand breaks resulting from collapsed DNA replication forks, replication errors, 
impairment of DNA repair pathways, and error-prone translesion synthesis [1, 2]. The 
accumulation of DNA damages can lead to many kinds of mutations, such as 
substitutions, insertions, deletions, or chromosomal rearrangements. Although genome 
instability can be harmful to cells and organisms, it drives evolution at the molecular 
level and generates genetic variation, such as immunoglobulin (Ig) diversification [3]. To 
maintain the genomic integrity and normal function of cells, several DNA repair 
pathways interplay and provide robust defense for the cells, including direct reversal of 
base damage, base excision repair (BER), nucleotide-excision repair (NER), mismatch 
repair (MMR), and double-strand break (DSB) repair [1]. In addition to the major types 
of DNA damages, such as base oxidation, base alkylation, base hydrolysis, base 
mismatch and strand break [1, 2] , the incorporation of ribonucleotides other than 
deoxyribonucleotides during DNA synthesis could be one form of DNA damage which 
has been overlooked for a long time.  
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1.2. rNMPs can be incorporated into chromosomal DNA 
Numerous studies provide evidence that ribonucleoside monophosphates (rNMPs) could 
be the most abundant among all the non-canonical nucleotides in genomic DNA (Figure 
1.1). DNA polymerases prevent the incorporation of  rNMPs during DNA synthesis 
efficiently [4] but not perfectly. Several in vitro studies showed that DNA polymerases 
involved in both DNA replication and repair can insert rNMPs during DNA synthesis 
assays ([5] and references therein), [6]. The pool of ribonucleotides is ~ 36- to 190-fold 
in excess over the pool of deoxyribonucleotides, increasing the chance of rNMPs to be 
stably incorporated into DNA [5]. In experiments involving primer extension using the 
same ribonucleotide and deoxyribonucleotide concentrations found in yeast cell extracts, 
the major yeast replicative DNA polymerases, DNA polymerases  (Pol ),  (Pol ) and 
 (Pol ), were all found to stably incorporate rNMPs into DNA [5]. These data raised the 
possibility that more than 10,000 rNMPs may be incorporated into the yeast nuclear 
genome during each round of replication [5]. Interestingly, regions of highly transcribed 
DNA in yeast cells were found to contain a high concentration of dUMP [7], and, 
possibly, these regions may also be hot spots for rNMP incorporation. In addition, DNA 
primases have very low fidelity, resulting in the incorporation of mispaired rNMPs, and 
could potentially leave one or several rNMPs embedded in chromosomal DNA by 
including deoxyribonucleotides in addition to ribonucleotides in the primer sequence [8, 
9]. Finally, oxidative damage of DNA can convert a deoxyribonucleotide in DNA to an 
rNMP [10].  
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Figure 1.1 Scheme of rNMPs present in genomic DNA. DNA is shown in blue; RNA 
is in red. 
 
The rNMPs incorporated in the DNA genome could pose a threat to the genome stability 
for their sensitivity to be cleaved or cause physical distortion of the DNA double helix, 
due to the presence of the reactive 2‟-hydroxyl moiety on the ribose ring [11]. What 
could the factors in a cell that can recognize and/or remove the rNMPs incorporated in 
DNA be? Ribonucleases H (RNases H), which have been shown to degrade RNA in an 
RNA/DNA hybrid in vitro [12, 13], can potentially remove rNMPs embedded in DNA to 
maintain genome stability. In addition, it is possible that DNA repair pathways can also 
be involved in the process of recognition and removal of rNMPs to maintain genome 
integrity. The NER repair enzymes recognize bulky distortions in the DNA duplex [14]. 
It is likely that the bulky ribose with a 2‟-hydroxyl group of an rNMP can cause DNA 
backbone distortion, which serves as a signal for recruiting NER repair enzymes to 
remove the single-strand DNA segment with the bulky lesion and fill in the gap with the 
correct dNMPs. The uracil of rUMP can be recognized and removed by DNA glycosylase 
in BER pathways [15]. Moreover, a base-base mismatch can form when a wrong rNMP is 
synthesized opposite to a dNMP during DNA replication or a wrong dNMP is 
synthesized through an rNMP tract. The base-base mismatch from an rNMP/dNMP 
mispair could potentially be recognized and removed by the DNA MMR pathway. Using 
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the oligonucleotide (oligo)-driven gene correction assays developed in our lab to form 
rNMP/dNMP hybrids in vivo, we started to investigate if the MMR system can recognize 
and remove rNMPs in the genome. 
 
1.3. The role of RNases H in the degradation of RNA/DNA hybrids  
RNases H are enzymes that hydrolyze the RNA strand of an RNA/DNA heteroduplex 
[12, 13]. RNases H are involved in DNA replication, transcription, recombination repair, 
and development[16]. Several in vitro biochemical studies indicate that RNases H 
participate in the removal of RNA primers during lagging-strand synthesis [17, 18]. 
RNases H are classified into two major families: RNase H type 1 and RNase H type 2 
[19]. The type 1 family includes yeast RNase H (1), mammalian RNase H1, prokaryotic 
RNase HI, and the RNase H domain of reverse transcriptase. The type 2 family includes 
yeast RNase H (2), mammalian RNase H2, prokaryotic RNases HII and HIII, and 
archaeal RNase HII [20].  
 
RNases HI/1 and RNases H II/2 have distinct cleavage patterns. RNases HI/1 require a 
substrate with an RNA stretch containing at least four ribonucleotides in a DNA duplex 
in order for cleavage to occur [21]. RNases HII exhibit a junction ribonuclease (JRNase) 
activity, which recognizes an RNA stretch in the RNA-DNA heteroduplex, such as an 
Okazaki fragment, and cleaves it, leaving a mono-ribonucleotide at the 5‟ terminus of the 
RNA-DNA junction. JRNase activity has not been reported for RNase HI/1 and 
prokaryotic RNases HIII [22]. RNase HII/2 can also recognize and cleave a single 
ribonucleotide embedded in a DNA duplex, suggesting that RNase H II/2 have a repair 
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function to cleave a mistakenly incorporated ribonucleotide in a DNA duplex [23]. 
Moreover, RNase HII from Chlamydia pneumoniae can cleave a DNA-rN1-DNA/DNA 
duplex containing various mismatches around or opposite to the ribonucleotide in vitro 
[24].  
 
RNase H1 and RNase H2 show clear differences in hybrid hydrolysis, indicating that they 
might have distinct in vivo substrates. More detailed analysis of substrate specificity for 
these two types of enzymes may help to elucidate the so far mostly elusive in vivo 
functions of RNase H1 and RNase H2 [20]. A recent in vivo study in yeast strains showed 
that a mutant form of DNA polymerase  (pol2-M644G) has an increased tendency to 
incorporate rNMPs into DNA [25]. The gene encoding the catalytic subunit of RNase H2 
in yeast is RNH201[26]. When the yeast RNH201gene was deleted, the pol2-M644G 
rnh201 strain appeared to accumulate rNMPs in genomic DNA and had an extended S-
phase and an increased rate of spontaneous mutagenesis that included 2–5 bp deletions in 
repetitive sequences [25]. These data indicate that rNMPs are incorporated during 
replication in vivo and are potentially removed by RNase H2-dependent repair. Failure to 
remove rNMPs could lead to a replicative stress response and destabilization of the 
nuclear genome. The deleterious effects could result from DNA distortions, which could 
affect the binding of proteins to DNA and/or possibly affect the activity of DNA or RNA 




Eukaryotic RNase H2 is a complex of three different proteins: the catalytic subuit (2A), 
similar to the monomeric prokaryotic RNase HII, and two other subunits (2B and 2C), 
which do not have prokaryotic counterparts and clearly known functions, but are 
necessary for catalysis [20]. RNase H1 has been implicated in mitochondrial DNA 
(mtDNA) replication during mouse development [27]. Mutations in any of the human 
RNase H2 subunits can result in Aicardi-Goutieres syndrome (AGS), a severe 
neurological disorder [28]. The symptons of AGS include progressive microcephaly, 
spasticity, dystonic posturing, profound psychomotor retardation, death in childhood [28, 
29]. So far, very little is known about the in vivo substrates of RNases H and which 
processes RNases H are involved in.  
 
1.4. Mismatch repair  
The DNA mismatch repair (MMR) machinery is a highly conserved genome surveillance 
system in bacteria, yeast and mammals that maintains genome integrity [30-32]. MMR is 
responsible for correcting practically any kind of DNA/DNA misalignments, including 
base-base mismatches and insertion/deletion loops (IDL). The base-base mismatches are 
mostly errors introduced by DNA polymerases that escape proofreading or small DNA 
lesions generated by intracellular metabolism (eg., oxidative stress) and external chemical 
agents. The IDLs are usually caused by misalignment of the microsatellite sequences due 
to strand slippage during DNA synthesis, resulting in different number of microsatellite 
units between the template and the newly synthesized strand [30, 33]. The absence of 
MMR leads to mutator phenotypes and a predisposition to cancer in humans [32]. 
Binding by MMR proteins and repair by MMR have a hierarchical pattern for the eight 
 7 
mismatch pairs: G-T, A-C, A-A, G-G>T-T, T-C, A-G> C-C [34, 35]. To our knowledge, 
nobody has examined if a mismatch between a DNA base and an RNA base can be 
recognized by the cellular MMR system. 
 
So far, mainly two types of MMR have been elucidated. One is employed by Escherichia 
coli and closely related bacteria (described in 1.4.1), and the other is employed by 
eukaryotes and the majority of bacteria (described in 1.4.2) [31]. 
 
1.4.1. Methyl-directed MMR in E. coli 
In E. coli, the recognition of mismatched DNA is mediated by a MutS homodimer, which 
recruits a homodimer of MutL (Figure 1.2). Then the ternary complex of MutS-MutL 
and DNA activates the endonuclease activity of MutH in an ATP-dependent manner [30]. 
Since the deoxyadenine methylase (DAM), which methylates adenines in the GATC sites 
lags behind the replication fork by ~2 minutes, the newly synthesized strand is transiently 
unmethylated. The MutS-MutL-activated MutH uses this time window to cleave a hemi-
methylated GATC site located within about ~1kb of the error, creating a nick for the 
entry point of the excision reaction [36, 37]. The UvrD helicase is loaded to the nick to 
unwind the error-containing DNA from the template [38]. The DNA-binding protein SSB 
binds to the single-strand template to stabilize it, and exonucleases digest the unwound 
DNA to remove the error either in a 5‟  3‟ direction or 3‟  5‟ direction depending on 
the location of the nick relative to the mismatch [39]. DNA polymerase III resynthesizes 
the strand to fill in the gap and the repair is completed when DNA ligase seals the 
remaining nick.  
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Figure 1.2 Scheme of the methyl-directed MMR in E. coli (from [40]) 
 
1.4.2. Mismatch recognition in eukaryotes 
In eukaryotes, the MMR has features in common with that in E. coli, but is more complex 
(Figure 1.3). MutS homologs (Msh), Msh2, Msh3 and Msh6 participate in MMR in the 
form of heterodimers [30]. Msh2-Msh6 (MutS ) initiates the repair of base-base 
mismatches and 1-2 base IDLs [41-43], whereas Msh2-Msh3 (MutS ) initiates the repair 
of larger IDLs containing up to 16 extra nucleotides in one strand [44]. The heterodimeric 
MutL homolog, MutL  (MLH-PMS2 in humans, Mlh-Pms1 in yeast) is involved in 
repairing a wide variety of mismatches. Other MutL homologs, yeast MutL  (Mlh1-
Mlh2) and yeast and human MutL  (MLH1-MLH3) participate in repairing a subset of 
IDLs. Although homologs of E. coli MutS and MutL exist in almost all organisms, no 
homolog of MutH has been identified in eukaryotes and most bacteria [30, 41]. In 
eukaryotes, differently from the methyl-directed mechanism in E. coli, strand 
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discontinuity serves as a signal that directs the targeting of MMR to the discontinuous 
strand. Discontinuities can exist as at the 3‟-ends of the newly synthesized leading stand 
or at the termini of Okazaki fragments of the newly synthesized lagging strand during 
DNA replication [31]. MutS  recognizes base-base mismatches and MutL  nicks the 5‟- 
or 3‟- side of the mismatched base on the discontinuous strand. The resulting DNA 
segment is excised by the Exo1 exonuclease in cooperation with the single-stranded DNA 
binding protein Rpa. The DNA strand is resynthesized by DNA polymerase  and the 
nick is ligated by DNA ligase I [30, 31].  
 
Figure 1.3 Scheme of the MMR in eukaryotes (from [45]) 
 
1.5. Application of oligos in the studies of DNA repair and modification 
Synthetic oligos are short single-strand DNA or RNA molecules. They are most 
commonly used as primers for DNA sequencing and amplification, probes for detecting 
complementary DNA or RNA via molecular hybridization, small interfering RNA, and 
tools to introduce the site-specific alterations. Particularly, oligos can be synthesized to 
contain a wide variety of base or sugar modifications to mimic specific nucleic acid 
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alterations. For example, a site-specifically modified O
6
-MeG DNA oligo was used to 
mimic O6-Methylguanine produced by endogenous and exogenous methylating agents in 
DNA [46].  It was found that the O
6
-MeG largely blocks the elongation of RNA 
polymerase and generates extensive base misincorporation opposite to O
6
-MeG in full 
length RNA [46]. Using an 8-oxoG containing oligo, it was revealed that 8-oxoGs are 
primarily repaired by the BER pathway and the repair is initiated by 8-oxoguanine DNA 
glycosylase (OGG) [47]. Therefore, oligos can serve as important tools for studying the 
effects of DNA damage and DNA repair mechanisms. In our study we have exploited the 
use of oligos to study mechanisms of MMR in the repair of RNA/DNA mismatches both 
in prokaryotic E. coli and in eukaryotic S. cerevisiae cells. 
 
1.5.1. DNA oligos-directed gene modification  
Single-stranded DNA (ssDNA) oligos have been used to edit the chromosomal DNA of 
different cell types, including E. coli, yeast and mammalian cells [48-51], ([52] and 
references therein). The Red recombination system of bacteriophage Lambda is 
extensively used in E.coli for efficient linear DNA recombination [49]. The Lambda Red 
system requires all three phage proteins Gam, Exo, and Beta for recombination between 
double stranded DNA (dsDNA) and the bacterial chromosome [53-55], whereas 
recombination with ssDNA oligos requires only Beta protein [49]. Beta protein binds to 
ssDNA, protecting it from degradation by nucleases and promoting the annealing to its 
complementary ssDNA [56, 57] (Figure 1.4). Recombination through the Lambda Red 
system using ssDNA exhibits high in vivo targeting efficiency and is not dependent on 
RecA in E. coli. Beta-dependent ssDNA recombination occurs at the replication fork, in 
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which the ssDNA oligos corresponding to Okazaki fragments, referred as the lagging-
strand oligos, always have higher efficiency for recombination than the leading-strand 
oligos [49, 55]. Single-strand DNA oligos generating a misalignment with the 
chromosomal sequence during the Lambda Red recombination process can activate the 
MMR system to remove the oligo sequence-generating mismatch. Thus, defects in the 
MMR system can enhance the recombination efficiency of the Lambda Red system by 
over 100-fold [34].  
 
Figure 1.4 Scheme of oligo-directed DNA modification via the Lambda Red 
recombination system in E. coli (modified from [34]). 
 
DNA oligos, homologous to the target sequence except for a single mismatch, were 
transformed into yeast cells to generate desired mutations on the reporter genes on 
chromosomal DNA [48, 58]. One limitation of this method is that the identification of 
genes with the introduced mutations requires a selectable phenotype. To overcome this 
limitation, an oligo-based genome targeting system, the delitto perfetto approach, was 
developed to provide in vivo site-directed DNA modification on almost any chosen 
chromosomal locus [52, 59]. The delitto perfetto includes two steps. The first step is to 
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integrate a counterselectable reporter (CORE) cassette into a chromosomal locus through 
the highly effient yeast homologus recombination system. The second step is to transform 
a designed oligo to replace the integrated CORE cassette. Rad52 is essential in the delitto 
perfetto approach, because both steps require homologous recombination [52]. The 
mechanism of oligo-mediated DNA modification in yeast cells is not as well 
characterized as in E. coli. The strand bias targeting for two complementary DNA oligos 
is not obvious in yeast cells [52, 58] (Shen et al. in press). In mammalian cells, DNA 
oligos have also been used to produce single-base alterations to genes on either episomal 
or chromosomal DNA [50, 51]; however, the oligo-mediated gene targeting is poorly 
efficient [60].  
 
1.5.2. DSB stimulates DNA modification by DNA oligos 
The generation of a DSB increases recombination frequency up to several thousand-fold 
from bacteria to human cells [61-64]. The break-mediated delitto perfetto approach 
developed in the yeast system is a simple and efficient approach for in vivo DNA 
modification using single-strand DNA oligos. The first step of this approach is to 
generate a specific DSB at the desired chromosomal location by inserting an inducible 
site-specific endonuclease (I-SceI) together with its cutting site. The second step is to 
target the chromosomal locus with designed oligos in such a way that the genomic 
sequence is modified with no remaining traces of the endonuclease gene and its site [62, 
65]. In the delitto perfetto-DSB system, the induction of the DSB stimulates oligo 
targeting more than 1,000‐fold [59, 62]. A DSB can also stimulate oligo-mediated gene 
correction in mammalian cells [66, 67]. Considering the high efficiency of recombination 
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driven by oligos in the presence of a DSB, it is possible to exploit this phenomenon, not 
only in gene targeting procedures, but also to study mechanisms of break repair using 
oligos with modified sequences of choice. 
 
1.5.3. RNA-templated DSB repair  
Previously, the capacity to repair a DNA DSB using homologous sequences was only 
attributed to DNA molecules [68]. RNA can be copied to DNA through reverse 
transcription in retroviruses, retrotransposons, and at telomeres [69, 70]. Reverse-
transcriptase (RT)-mediated events were observed in DSB repair, in which mRNA was 
converted to complementary DNA (cDNA) within yeast retrotransposon Ty1 particles 
and inserted at the break site of an HO endonuclease induced DSB at the mating type 
(MAT) locus [71, 72]. Such repair events do not involve homology between the RNA and 
the broken DNA, thus the repair of the broken DNA region containing an insertion could 
be mutagenic. Although several studies have reported direct interaction of RNA with 
chromosomal DNA, none of them involves DNA repair. An RNA transcript can be used 
as a primer by the E. coli replisome to continue leading-strand synthesis after a co-
directional collision with RNA polymerase [73]. Artificial RNA templates injected into 
Oxytricha, a Ciliata Protozoa, were shown to mediate correct and precise DNA 
rearrangements, suggesting that RNA molecules can guide genome rearrangements [74]. 
Moreover, RNA can invade a DNA duplex and pair with the complementary DNA to 
form a three-strand R-loop structure both in vitro [75] and in vivo [76].  
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Synthetic RNA-only and RNA-containing oligos were found to serve as templates for 
DNA synthesis during the repair of a chromosomal DSB in yeast [77] (Figure 1.5). Much 
evidence was provided in this study that RNA can function as a direct template for DNA 
synthesis in a homology driven manner during DSB repair. The repair frequency declined 
with the increased size of the RNA tract when the length of the RNA tract was larger than 
4 bp, suggesting that cDNA generated by Ty reverse transcriptase was unlikely to be a 
source of DSB repair. The deletion of the SPT3 gene, which is essential for transposition 
and transcription of Ty1 and Ty2 elements, or the deletion of telomerase genes, EST1 or 
EST2, did not affect the DSB repair events mediated by a homologous RNA template [78, 
79]. Another evidence that RNA serves as a direct template is based on the fact that 
RNA-containing oligos have the same strand-bias targeting as their corresponding DNA-
only oligos [77]. The strand-bias targeting was first identified by using synthetic DNA 
oligos [80] to correct a genetic defect in a reporter gene positioned downstream from a 
DSB site (Figure 1.6). Following the formation of the DSB, the 5‟ ends of the break are 
resected, exposing long 3‟ single-strand DNA ends. The synthetic DNA oligo 
complementary to the 3‟ end can anneal with the exposed ssDNA end on the 
chromosome, while the oligo complementary to the 5‟ end of the break cannot anneal 
with the 5‟ end if this has been degraded, and thus, it cannot serve as template to correct 
the defect in the reporter gene. Therefore, the oligo complementary to the 3‟ end of the 
break is more efficient at gene correction than the oligo complementary to the 5‟ end of 
the break. If the RNA-containing oligos are reverse transcribed to complementary single-
strand DNA, the bias for these oligos would be opposite to the bias observed for the 
corresponding DNA-only oligos. If the RNA-containing oligos are reverse transcribed to 
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double strand cDNA, there would be no strand bias because the oligos would be double 
stranded. In the experiments presented in Figure 1.6, the RNA-containing oligos 
presented the same strand bias as the corresponding DNA-only oligos, thus excluding the 
possibility of reverse transcription [77]. The overall findings of this study established that 
a direct homologous exchange of genetic information can occur between RNA and DNA 
in yeast cells.  
 
Figure 1.5 Repair of a DSB by RNA-containing oligos (modified from [77]). A DSB is 
induced in the LEU2 gene on the yeast chromosome. RNA-containing oligos, RNA-only 
oligos, and their corresponding DNA oligo are transformed to repair the DSB. DNA is 
shown in blue; RNA is shown in red. Repair frequency and sequencing results of the 
repaired LEU2 gene are shown on the right.  
 16 
 
Figure 1.6 Strand bias targeting of RNA-containing oligos and their complementary 
DNA-only oligos (modified from [77]).  W: oligo complementary to the 3‟ end; C: oligo 
complementary to the 5‟ end.  
 
RNA-only and RNA-containing oligos have relatively low repair efficiency compared 
with their corresponding DNA oligos [77]. Two possible explanations are that (1) a single 
strand RNA is readily degraded by exonucleases [81, 82], (2) an RNA tract bound to 
DNA in an RNA/DNA hybrid can be easily recognized by RNase H1 and/or RNase H2 
[20], which then cleave the RNA tract and prevent the repair. Studying the specificity of 
RNases H1 and RNases H2 in vivo will help to decipher the mechanism of RNA-






1.6. RESEARCH GOALS 
1.6.1. To explore the phenomenon of RNA-mediated DNA repair and modification 
in bacteria and human cells.  
Our previous studies have demonstrated that RNA can serve as a template for DSB repair 
in the yeast S. cerevisiae using synthetic RNA-containing oligos. Here, we hypothesize 
that RNA-mediated DNA repair and modification is conserved in both prokaryotic and 
eukaryotic cells. We have developed an assay in the bacterium E. coli to correct a 
defective lacZ marker gene using RNA-containing oligos as a template. We have also 
utilized RNA-containing oligos to repair a DNA DSB in the green fluorescent protein 
(GFP) gene located either on a plasmid or in the genome in human embryonic kidney 
(HEK-293) cells.  
 
1.6.2. To develop a molecular approach to generate RNA/DNA hybrids in genomic 
DNA. 
RNA/DNA hybrids can form during DNA replication, repair and transcription. However, 
very little is known about the stability of RNA/DNA hybrids in cells and to which extent 
RNA/DNA hybrids can affect the genome integrity. Therefore, it is important to develop 
a molecular approach to generate RNA/DNA hybrids in vivo. We have set up a procedure 
for the incorporation of ribonucleotides into the genome of cells, starting with the 
eukaryotic model system yeast S. cerevisiae. This procedure to generate RNA/DNA 




1.6.3. To identify the protein factors and DNA repair mechanisms that can target 
mispaired rNMPs embedded in DNA. 
Numerous studies support the hypothesis that rNMPs are abundant in genomic DNA. We 
propose that the rNMPs in genomic DNA can form RNA/DNA mispairs, which could be 
a target for RNases H and DNA repair mechanisms, such as the DNA mismatch repair 
(MMR) system. To understand to what extent rNMPs may alter genome integrity and 
what factors affect their stability, we have utilized oligo-driven gene correction assays in 
the bacterium E. coli and the yeast S. cerevisiae and we have examined gene correction 
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As recently demonstrated in the yeast Saccharomyces cerevisiae model organism using 
synthetic RNA-containing oligonucleotides (oligos), RNA can serve as a template for 
DNA synthesis at the chromosomal level during the process of double-strand break 
(DSB) repair. Herein we show that the phenomenon of RNA-mediated DNA 
modification and repair is not limited to yeast cells. A tract of six ribonucleotides 
embedded in single-strand DNA oligos corresponding to either lagging or leading strand 
sequences could serve as a template to correct a defective lacZ marker gene in the 
chromosome of the bacterium Escherichia coli. In order to test the capacity of RNA to 
modify DNA in mammalian cells, we utilized DNA oligos containing an embedded tract 
of six ribonucleotides, as well as oligos mostly made of RNA. These oligos were 
designed to repair a chromosomal break generated within a copy of the green fluorescent 
protein (GFP) gene randomly integrated into the genome of human HEK-293 cells. We 
show that these RNA-containing oligos can serve as templates to repair a DSB in human 
cells and can introduce base changes into genomic or plasmid DNA. In both E. coli and 
human cells, the strand bias of chromosomal gene correction by the single-strand RNA-
containing oligos was the same as that obtained for the corresponding DNA molecules. 
Therefore, the RNA-containing oligos are not converted into a cDNA before annealing 
with complementary DNA. Overall, we demonstrate that in both bacterial and human 







In the central dogma of molecular biology, information flows from DNA to RNA. 
Information can be transferred from RNA to DNA by reverse transcription only in the 
special cases of retroviruses, retrotransposons and telomerase [83, 84]. Could there be 
functions for RNA-driven DNA modifications of which we are unaware? There might be 
profound implications in molecular biology if transfer of genetic information from RNA 
to DNA could be shown to be more general in nature.  
 
Among the many roles ascribed to RNA in cells, we recently revealed that RNA can 
function as a template for double-strand break (DSB) repair and directly transfer 
information to chromosomal DNA in a model organism, the yeast Saccharomyces 
cerevisiae [25, 77]. Previously, the capacity to repair a DNA DSB by a homologous 
template molecule was attributed to pure DNA molecules [68], and none of the known 
DNA repair pathways had ever been shown to utilize RNA as a template. Reverse-
transcriptase (RT)-mediated events were observed in DSB repair in yeast strains, in 
which mRNA was copied into DNA (cDNA) and inserted at an HO endonuclease-
induced DSB at the mating type (MAT) locus [85, 86], or was used as a template for gene 
conversion with homologous genomic sequences [87, 88]. While yeast RT from the yeast 
transposon Ty is confined in the cytoplasm inside Ty particles [89], in human cells it was 
found that retrotranscription can be primed in the nucleus by the 3‟ end of a chromosomal 
break that captures the poly-A tail of a LINE1 retrotransposon RNA [90]. However, such 
events of break repair via LINE1 RNA did not involve homology between the RNA and 
the broken DNA. As reviewed by Storici [91], there have been prior speculations, 
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although without evidence, that RNA can be used as template in DNA repair or to 
directly transfer genetic information to genomic DNA. Differently, our data showed that 
RNA-containing oligonucleotides (oligos) with homology to a broken chromosome can 
efficiently repair a DSB under conditions where the previously described cDNA-
dependent RNA repair processes were inactivated [77]. While there are several studies 
reporting the direct interaction of RNA with genomic DNA, none involve DNA repair or 
homologous targeting. In fact, RNA can invade a DNA duplex and pair with a 
complementary DNA region not only in vitro [92] but also in vivo [93], forming three 
strand R-loop structures, which have been regarded as sites of DNA replication in 
bacterial and mitochondrial DNA [94, 95]. RNA-guided DNA alterations were shown in 
Tetrahymena [96] and Paramecium [97]. Moreover, artificial RNA templates injected 
into the protozoa Oxytricha trifallax were recently shown to mediate correct and precise 
DNA rearrangements, suggesting that RNA molecules can guide genome modifications 
[96], thus supporting our results in yeast.   
 
To further exploit the use of RNA-containing oligos, we have set up a procedure to 
generate desired RNA/DNA hybrids at the chromosomal level in vivo starting with the 
yeast system [98]. We have thereafter established that, in yeast S. cerevisiae and bacteria 
E. coli cells, mispaired ribonucleotides embedded in chromosomal DNA are sources of 
genetic modification (Shen et al., in press).  In the present study, we demonstrate that the 
capacity of RNA to transfer genetic information to DNA is conserved from a prokaryotic 
to higher eukaryotic cell system, i.e. human cells. We also exclude the possibility that 
RNA-driven modification might be mediated by a cDNA reverse transcript. The results 
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we present, deviating from the central dogma of molecular biology, shed light on the 
capacity of RNA to play an active role in DNA editing and remodeling, which could be 























2.3. MATERIALS AND METHODS 
 
2.3.1. E. coli strain and procedures.  
The E. coli strain used in this study is BW1892 (mutS::Gm cI857 (cro-bio) lacZ [ GG 
(nt 1370-71); nt 1384 G→A]) [99], which has an AAG (Lac
-
) codon in place of the GAG 
(Lac
+
) codon of the wild type strain that differs from the GAA (glutamate) codon in the 
official sequence. The GG deletion prevents spontaneous reversion. Lac
+
 transformants 
will have acquired both the GG segment and the GAG codon from the transforming 
oligos. The E. coli strain BW1892 has a mutS mutation and is thermoinducible for the 
beta protein of phage lambda, which makes it transformable by oligos [100]. LB media 
was used for routine growth. Lac
+
 recombinants were selected on 1.5% agar plates 
containing Vogel-Bonner Medium E supplemented with lactose (0.1%), thiamine (1 
g/ml), and biotin (0.8 g/ml) [99]. Transformations with single-stranded oligos were 
performed as previously described [100] using 100 ng of oligo per 50 l of 
electrocompetent cells.  
 
2.3.2. Human cell lines, plasmids and procedures.  
Human embryonic kidney (HEK-293) cells were grown in Dulbecco‟s modified Eagle‟s 
medium, DMEM (Mediatech, Inc. Manassas, VA), supplemented with 10% heat-
inactivated fetal bovine serum (Gemini, Bio-Products, West Sacramento, CA) and 1X 
Penicillin/Streptomycin (Lonza, Walkersville, MD). Cells were grown at 37˚C in a 5% 
CO2 humidified incubator. 658D cells are HEK-293 derivative cells containing a 
randomly integrated copy of the GFP gene disrupted by a 35-bp region containing a stop 
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codon and the cutting site for the I-SceI endonuclease [101]. Plasmid pA568 contains the 
GFP gene disrupted by the same 35-bp region containing the site for the I-SceI 
endonuclease and is expressed under the CMV/CBA promoter [101]. Plasmid pA961 
contains the I-SceI endonuclease gene expressed under the CMV/CBA promoter [101]. 
Cells were transfected using polyethylenimine (PEI, Polysciences, Warrington, PA) 
transfection reagent in 24-well plates at a density of ~50,000 cells per well [102, 103]. In 
all transfection experiments in human cells, plasmid DNA was used in the amount of 0.5 
g while oligo DNA was 1.5 g, unless otherwise indicated. In these experiments, the 
oligos and the plasmid were diluted in DMEM without supplements, vortexed in the 
presence of PEI, and then added to the wells 10 min later. Under these conditions, 
transfection of 0.5 g of GFP expressing plasmid resulted in 80.5% GFP positive HEK-
293 cells and 76% GFP positive 658D cells. Green fluorescent cells were visualized by 
fluorescent microscopy using a Zeiss Observer A1 microscope and an AxioCam MRm 
camera (Zeiss, Thornwood, NY). Frequencies of GFP positive cells were obtained by 
flow cytometric analysis using the BD LSR II Flow Cytometer (BD Biosciences, Sparks, 
MD). Either 50,000 or 100,000 cells were counted for each sample. Sorting of GFP 
positive cells was performed using the BD FACS Aria Cell Sorter (BD Biosciences). 
 
2.3.3. Oligos and oligo alkali treatment.  
DNA oligos were synthesized by Invitrogen (Carlsbad, CA) and Alpha DNA (Montreal, 
Quebec, Canada), while RNA-containing oligos were synthesized by Thermo Fisher 
Scientific (Dharmacon brand, Lafayette, CO) (Table 2.1). For experiments in E. coli 
cells, to establish the presence of ribonucleotides by using alkaline sensitivity, oligos at 5 
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g/ l were incubated for 1 h at 65°C in water (no treatment) or in 0.5 M NaOH followed 
by neutralization with HCl 1.2 M and Tris-HCl 1 M pH 7.4. A high concentration of 
oligo was used to enable sufficient subsequent dilution of salt before electroporation. 
Transformations of bacterial cells were completed as described above with 100 ng of 
oligo. For experiments in human cells, 4 nmoles of oligos were treated with 1 M NaOH at 
65° C for 1 h, and then neutralized with HCl 1.2 M and Tris-HCl 1 M pH 7.4. 
Alternatively, 4 nmoles of the same oligos were resuspended in water and Tris-HCl 1 M 
pH 7.4. 1.5 g of oligos were used in the transfection experiments as described above. 
 
2.3.4. Standard genetic and molecular biology techniques. 
Standard genetics and molecular biology analyses were performed as previously 
described [77, 99]. PCR from the E. coli genome was performed by introducing single 
colonies directly into the PCR mix for the Taq Roche DNA polymerase (Basel, 
Switzerland) and using primers LacZ1201F: 5‟-ACCGCTACGGCCTGTATGTG  and 
LacZ1703R: GACGAAGCCGCCCTGTAAAC). Purified PCR products were submitted 
for sequencing to Eurofins MWG Operon (Huntsville, AL). To verify the sequence of the 
GFP DNA targeted by the DNA and the RNA-containing oligos in the human cells, green 
fluorescent sorted cells were utilized for genomic DNA extraction according to the 
DNeasy Blood & Tissue Kit (Qiagen, Valencia, CA). The extracted genomic DNA was 
used as a template to amplify the sequence of the GFP marker using primers GFP.1 (5‟- 
atggtgagcaagggcgaggagctg) and GFP.2 (5‟- ttacttgtacagctcgtccatgcc) using iProof High 
Fidelity DNA Polymerase (BioRad, Hercules, CA). The PCR products obtained were run 
in an agarose gel to verify the correct size and were then cloned using the Zero Blunt 
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TOPO PCR Cloning Kit (Invitrogen) according to the instructions. The GFP sequence 
was then determined by sequence analysis using the standard primers for the SP6 
























Table 2.1 DNA sequences of the oligos used in this study and of part of the GFP locus disrupted by the I-SceI site 
 
The structure of the oligos used in this study is described from the 5’end, with DNA sequences (D) shown in blue and RNA sequences (R) in 
red. Bases with homology to the chromosomal DNA are shown in brackets and underlined. Insertions are indicated as “ins::”. Mismatches 
are indicated as “m”. The sequence of the oligos is shown from the 5’ end; the sequence changes introduced by the oligos are bolded and 
shown in blue if these consist of DNA bases and in red, with a lower case “r” on the left side if these consist of RNA bases.  The BssHII 
restriction site is underlined in the sequence of the GFP targeting oligos. The DNA oligos were desalted. The RNA–containing oligos were 
desalted and deprotected.  
The tract of the GFP sequence disrupted by a 35-bp region containing the 18-bp I-SceI cutting site is shown at the bottom. The I-SceI site is 
underlined. 
Name Size Structure from 5’ Sequence 
LacZ.D 65 [D 24] ins::D 2 [D 12] mD 1 [D 26] 5'-GTAATCACCCGAGTGTGATCATCTGGTCGCTGGGGAATGAGTCAGGCCACGGCGCTAATCACGAC 
LacZ.D comp 65 [D 26] mD 1[D 12] ins::D 2 [D 24] 5'-GTCGTGATTAGCGCCGTGGCCTGACTCATTCCCCAGCGACCAGATGATCACACTCGGGTGATTAC 
LacZ.R6 65 [D 22 R 2] ins::R 2 [R 2 D 10] mD 1 [D 26] 5'-GTAATCACCCGAGTGTGATCATCUrGrGUCGCTGGGGAATGAGTCAGGCCACGGCGCTAATCACGAC 
LacZ.R6 comp 65 [D 26] mD1 [D 10 R 2] ins::R 2 [R 2 D 22] 5'-GTCGTGATTAGCGCCGTGGCCTGACTCATTCCCCAGCGArCrCAGATGATCACACTCGGGTGATTAC 
GFP80.D 80 [D 39] mD 1 [D 40] 5'-GCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACGCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACC 
GFP80.D comp 80 [D 40] mD 1 [D 39]  5'-GGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGCGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGATGGTGCGC 
GFP.D 66 [D 32] mD 1 [D 33] 5'-ATCTTCTTCAAGGACGACGGCAACTACAAGACGCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG 
GFP.D comp 66 [D 33] mD 1 [D 32] 5'-CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGCGTCTTGTAGTTGCCGTCGTCCTTGAAGAAGAT 
GFP.R6 66 [D 30 R 2] mR 1 [R3 D 33] 5'-ATCTTCTTCAAGGACGACGGCAACTACAAGACrGCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG 
GFP.R6 comp 66 [D 30 R 3] mR 1 [R 2 D 32] 5'-CAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGrCGUCTTGTAGTTGCCGTCGTCCTTGAAGAAGAT 
DT_GFP.R 80 [R 29] mR 1 [R 30] D 20 tail 5'-UUCUUCAAGGACGACGGCAACUACAAGACrGCGCGCCGAGGUGAAGUUCGAGGGCGACACC-CCAGCGGAGTCCTTGGCCTA 
GFP80.R 80 [R 39] mR 1 [R 40] 5'-GCGCACCAUCUUCUUCAAGGACGACGGCAACUACAAGACrGCGCGCCGAGGUGAAGUUCGAGGGCGACACCCUGGUGAACC 
GFP::I-SceI site  5’---ATCTTCTTCAAGGACGACGGCAACTACAAGACC-TAAGCTCTCGAGATTACCCTGTTATCCCTAAGCTT-CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG--- 
 29 
2.4. RESULTS AND DISCUSSION 
 
2.4.1. RNA-driven gene correction in E. coli.  
 The capacity of RNA to modify genomic DNA is not limited to DSB repair. From 
experiments we performed, both in S. cerevisiae and in E. coli, we have found that RNA 
can serve as a template for genomic DNA modifications in circumstances where a DSB 
was not induced [77, 91, 98] (Shen et al, in press). When we first demonstrated RNA-
driven DNA modifications in yeast cells we excluded the possibility that RNA was 
copied by a reverse transcriptase enzyme and converted into a cDNA intermediate before 
serving as template for DNA synthesis at the chromosomal level [77]. We exploited the 
finding that a DSB can activate strong strand-biased targeting by ssDNA oligos with 
homology to loci distant from the DSB site [80]. If a cDNA intermediate were formed 
from single-stranded RNA-containing oligos, the observed bias should have been 
opposite to that with the corresponding single-stranded DNA oligos, and there would 
have been no bias if double-stranded DNA were formed. As we previously showed [77], 
targeting with RNA-containing oligos was biased similarly to DNA-only oligos. 
Moreover, after eliminating the major sources of RT in yeast from Ty1 and Ty2 or 
telomerase by deleting the SPT3 gene or the EST1 and EST2 genes, respectively, the 
frequency of RNA-templated DNA repair by multiple RNA-containing oligos remained 
similar to that obtained in wild-type cells in yeast [77]. Therefore, our data clearly 
demonstrated that the RNA-containing oligos can directly transfer genetic information to 
chromosomal DNA.  
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Unlike yeast cells that express the RT from the Ty transposons and from telomerase, E. 
coli K-12 and derivative strains do not have any RT [104] that could reverse transcribe 
the RNA-containing oligos into cDNA. Although all of our E. coli strains derive from the 
K-12 strain, to completely exclude the possibility that the RNA-containing oligos could 
be copied into DNA before interacting with the E. coli chromosomal DNA, we took 
advantage of the fact that gene correction by single-strand oligos in E. coli is known to be 
strongly affected by the direction of DNA replication. Specifically, in the λ 
recombination system, single-strand DNA oligos corresponding to lagging strand 
sequences are 10 to 100-fold more efficient at gene targeting than the complementary 
single-strand oligos corresponding to the leading strand [105]. Because of the strong 
strand bias for transformation, it is believed that the transforming oligos bind to the 
chromosome at the replication fork, in the gaps between the Okazaki fragments, and are 
subsequently joined to the lagging strand, thereby becoming templates for gene 
correction in the next round of DNA replication [105]. We hypothesized that if the RNA-
containing oligos were interacting directly with chromosomal DNA these should display 
the same strand bias targeting as the corresponding DNA oligos. We, therefore, 
investigated the capacity of lagging and leading-strand oligos containing an RNA tract to 
transfer information to chromosomal DNA in bacterial cells, utilizing the E. coli strain 
BW1892 (see section 2.3.1). Strain BW1892 contains a defective lacZ gene in the 
bacterial genome. The lacZ mutant gene carries a missense mutation (GAG in place of 
AAG), and an additional 2-nucleotide (nt) deletion (deletion of GG) upstream from the 
substitution prevents spontaneous reversion to Lac
+ 
[99]. The BW1892 strain also 
contains a partially deleted prophage that expresses the Beta and exonuclease 
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recombination proteins of  under the thermoinducible control of the cI857 repressor. 
The Beta protein enables the efficient incorporation of electroporated oligos into DNA 
[100]. The mutS mutation in the host enhances the frequency of transformation by 
blocking mismatch repair, which would otherwise impede transfer of information from 
the oligos to the chromosomal DNA [100]. This strain can be efficiently transformed to 
Lac
+
 with appropriate oligos that substitute the mutant G into an A and reintroduce the 
missing GG bases (Figure 2.1). Two RNA-containing oligos were used to correct these 
mutations. One brought back in the missing GG bases present within a 6-base RNA tract 
embedded in the DNA sequence of a 65-nt single-strand molecule also containing the 
correct „A‟ to replace the „G‟ of the substitution mutation (LacZ.R6); the second was the 
complementary oligo (LacZ.R6 comp) (Table 2.1 and Figure 2.1). These 6-RNA base-
containing oligos and the corresponding DNA-only molecules (LacZ.D and LacZ.D 
comp) were transformed into the E. coli BW1892 strain. If the information is correctly 
transferred from the oligo to the chromosome, bacteria cells become Lac
+
. Transformant 
colonies were obtained on the selective media. Results are shown in Table 2.2. The 
DNA-only oligo of the lagging strand could correct the defective lacZ gene 12.2-fold 
more efficiently than the complementary DNA-only oligo of the leading strand. In the 
BW1892 background, the RNA-containing oligo LacZ.R6 of the lagging strand could 
serve as a template for gene correction. Importantly, gene correction by the LacZ.R6 
oligo was over two orders of magnitude (286-fold) more efficient than the LacZ.R6 comp 
oligo of the leading strand, revealing a strong strand bias in favor of the RNA-containing 
oligo of the lagging strand (Table 2.2). Barring an unknown mechanism for reverse 
transcription biased towards very specific sequences in E. coli K12, such as the sequence 
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of the LacZ.R6 oligo, our data demonstrate that the RNA-containing oligos are not copied 
into cDNA before interacting with chromosomal DNA in E. coli, and can thus be used as 
templates for DNA synthesis directly at the chromosomal level. 
 
The ability of both the RNA-containing oligos of the lagging and leading strands to 
transfer information to chromosomal DNA in E. coli cells was clearly not due to 
contamination with the DNA oligos. Pretreatment with alkali (NaOH) before 
transformation with oligos almost abolished gene correction by the RNA-containing 
oligos (Table 2.3). Therefore, the number of Lac
+
 transformants produced by the 
LacZ.R6 oligo was much greater than what could be explained by DNA contamination 




 cells). Five Lac
+
 transformants 
obtained with the RNA-containing oligo LacZ.R6 and five obtained with oligo LacZ.R6 
comp were sequenced in the lacZ region. The chromosomal sequences were identical to 
the oligo sequences in 5/5 samples targeted by the LacZ.R6 oligo and in 4/5 samples 
targeted by the LacZ.R6 comp oligo (data not shown). One clone targeted by the LacZ.R6 
comp oligo displayed two additional substitutions (one within the sequence derived from 
the RNA tract of the oligo and one within the sequence derived from the DNA tract of the 
oligo), probably due to errors during oligo synthesis [52]. Overall, these results 
demonstrate that E. coli cells can utilize RNA as a template for DNA synthesis at the 
chromosomal level. Thus, RNA-containing molecules can be a source of genetic changes 







Figure 2.1 Scheme of the E. coli chromosomal region with the lacZ gene mutated 
and then repaired by the LacZ.R6 oligo or the LacZ.R6 comp oligo. DNA bases are 





















LacZ.R6 189 (155-249) 
 
Lagging 
LacZ.R6 comp 0.66 (0.06-0.94) 
 
Leading 
LacZ.D 9,750 (8,060-12,400) 
 
Lagging 
LacZ.D comp 798 (364-1,480) 
 
Leading 




Median and 95% confidence interval (in parentheses), or alternatively the range when the 
number of repeated experiments was <6, of E.coli Lac
+
 transformant colonies reverting 
the two-base deletion mutation and one-base missense mutation per 10
7
 viable cells. 
†
The 




Table 2.3 Alkali lability of RNA-containing oligos in E. coli 
Oligos Lac
+
 colonies w/o NaOH Lac
+
 colonies w/ NaOH 
LacZ.R6 583 (394-772) 0.63 (0.31-0.63) 
LacZ.R6 comp 0.47 (0-0.79) <0.1 (0-0) 
LacZ.D 15,300 (9,130-18,300) 4,100 (1,900-5,510) 
LacZ.D comp 1,300 (1,220-1,850) 542 (441-611) 




Median and range (in parentheses) of Lac
+
 transformant colonies, per 10
7
 viable cells, following 








2.4.2. RNA-mediated chromosomal repair in human cells.  
We previously reported that the induction of a DSB stimulates up to 10,000-fold the gene 
correction frequency by both DNA and RNA-containing oligos in yeast cells [62, 77]. In 
mammalian cells, where homologous gene correction is very inefficient, a DSB was also 
shown to stimulate gene targeting [64, 101, 106]. More than 0.3% of human HEK-293 
cells were corrected by DNA oligos when an I-SceI DSB was induced at the target gene 
and the oligos had sequence corresponding to the sense strand of the target gene [107]. 
With the goal of detecting gene modification by RNA-containing oligos in mammalian 
cells, we exploited the break induction system developed by Porteus and Baltimore in 
HEK-293 derivative cells (658D cells) [101]. The 658D cell line contains a copy of the 
green fluorescent protein (GFP) gene randomly integrated into the genome of the HEK-
293 cells and disrupted by a region containing the site for the I-SceI endonuclease [101] 
(Table 2.1). A DSB can be induced in the middle of GFP by transfecting the 658D cells 
with a plasmid that expresses the I-SceI endonuclease [101]. To test if RNA-containing 
oligos could be used to repair a DSB generated in the genome of human cells and transfer 
genetic information to genomic DNA, we designed several oligos containing RNA tracts 
of different lengths and with homology to both sides of the I-SceI-break site in the GFP 
gene of the 658D cells (Table 2.1). These oligos were tested for their ability to mediate 
break repair and restore the functionality of the GFP marker gene (Figure 2.2A and 
Table 2.1). All oligos were also designed to contain a silent mutation in GFP to generate 
a BssHII restriction site (Table 2.1). Initially, the RNA-containing oligo GFP.R6 or the 
corresponding control DNA-only oligo GFP.D was cotransfected together with the I-SceI 
endonuclease-expressing vector into the 658D cells. Remarkably, the RNA-containing 
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oligo GFP.R6 generated green fluorescent cells following transfection in human cells 
(Figure 2.2B). The repair frequency of GFP by the different oligos was determined by 
flow cytometric analysis. As shown in Figure 2.2C, the GFP.R6 oligo containing a tract 
of 6 ribonucleotides was able to restore the functionality of GFP and presented a repair 
frequency only 4.4-fold less than the corresponding DNA oligo GFP.D. To determine 
whether oligos with an RNA-only region homologous to the broken chromosomal GFP 
marker gene could also serve as a template for break repair and DNA modification, we 
designed oligo DT_GFP.R with 60 RNA bases homologous to GFP and a 3‟-DNA non-
homologous tail of 20 bases (Table 2.1). As previously demonstrated in our yeast study, 
an oligo containing 60 RNA bases with homology to broken yeast chromosomal ends and 
a 20-base non homologous DNA tail at the 3‟ end was about 100-fold more effective at 
DSB repair than a corresponding RNA-only molecule [77]. The DNA tail is designed to 
protect the RNA portion from degradation by nucleases and does not participate in the 
repair process. Following transfection of oligo DT_GFP.R in the 658D cells, we found 
that this oligo generated a significant number of green fluorescent human cells with a 
frequency of 1/100,000 cells (Figure 2.2C). In the absence of oligos, the frequency of 










Figure 2.2 Chromosomal DNA modifications mediated by RNA-containing oligos in 
human cells. (a) Scheme of the human chromosomal region with the GFP gene cut by 
the I-SceI endonuclease and then repaired by the GFP.R6 oligo. DNA bases are shown in 
blue and RNA bases in red with a small „r‟ on the left. (b) Micrograph at 40x of human 
green fluorescent cells (pointed to by the white arrows) targeted by the RNA-containing 
oligo GFP.R6. (c) Frequencies of human GFP
+
 cells repaired by the DNA oligo (blue 
bar) or the RNA-containing oligos (red bars) per 50,000 transfected cells; median (value 
shown at the top right of each bar) and range are shown. While the median is 0.0, there 
were <1/400,000 GFP
+
 cells for the „Cells‟ sample and 1/250,000 in average for the „No 
oligo‟ sample. Except for the „Cells‟ sample, the „No oligo‟ and the „Oligos‟ samples 
were transfected together with the plasmid expressing the I-SceI endonuclease. A sketch 
of chromosomal GFP repair by oligos is shown above the graph.  
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To exclude the possibility that DNA contamination in our GFP RNA-containing oligos 
was responsible for the transfer of genetic information, we treated the RNA-containing 
and DNA-only oligos with alkali prior to the experiment of gene correction at the 
chromosomal level (Figure 2.3A) or at the plasmid level (Figure 2.3B, as presented in 
section 2.4.4). Data presented in Figure 2.3A show that targeted repair of the 
chromosomal GFP was strongly reduced after alkali treatment of the RNA-containing 
oligos, thus excluding contamination with homologous DNA sequences in our RNA-
containing oligo solutions. To confirm that correction of the GFP gene was due to oligo 
targeting and not by repair through end joining, green fluorescent cells obtained from 
GFP.R6 and GFP.D oligos were sorted. After sorting, the population of green fluorescent 
cells reached ~ 75%, and 10
6
 cells were prepared for genomic extraction. Genomic DNAs 
from the extracts were then used in PCR reactions to amplify the GFP gene (Figure 2.4). 
The PCR products were cloned using the Zero Blunt TOPO PCR Cloning Kit and 
digested with BssHII or I-SceI to verify the correction of the GFP gene. About 36% 
(20/55) of the TOPO clones analyzed and derived from sorted green fluorescent cells 
targeted by GFP.R6 were still cut by I-SceI, and ~10% (5/55) were cut by BssHII. We 
sequenced 4 samples cut by BssHII, and all 4 had the sequence carried by the RNA-
containing oligo with no additional mutations. Of the remaining 54% of clones, 6 were 
sequenced, and none were shown to contain the GFP sequence (not shown). The presence 
of uncorrected GFP sequences can be explained by the fact that even after sorting of the 
green fluorescent cells, there were still several non-fluorescent cells present (~ 25%, not 
shown). Two clones cut by BssHII derived from cells targeted by the DNA-only oligo 
GFP.D were sequenced and contained no other additional mutations beyond the expected 
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BssHII site (data not shown). These data showed that an RNA-containing oligo, similarly 
to a corresponding DNA-only molecule, can serve as a template to repair the broken GFP 
























Figure 2.3 Alkali lability of RNA-containing oligos in human cells. Frequencies in 
Log scale of human GFP
+
 cells repaired at the (a) chromosomal level or (b) the plasmid 
level by the DNA oligo following no treatment (-NaOH, blue bar) or treatment with 
alkali (+NaOH, blue bar with stripes), or by the RNA-containing oligo following no 
treatment (-NaOH, red bar) or treatment with alkali (+NaOH, red bar with stripes) per 
50,000 transfected cells; median and range are shown. Sketches of chromosomal and 












Figure 2.4 Detection of GFP bands following PCR from genomic DNA of human 
green fluorescent cells targeted by the DNA-only oligo GFP.D or the RNA-
containing oligo GFP.R6. Lane 1, 1 kb DNA Ladder; lane 2, GFP band amplified from 
the pA658 vector containing a region with the I-SceI site in the middle of GFP (755 bp); 
lanes 3 and 4, no PCR product detected from HEK-293 cells; lanes 5-8, GFP product 
(720 bp) from sorted green fluorescent 658D cells targeted by oligo GFP.D; lanes 9-12, 








2.4.3. RNA-containing oligos have the same strand bias as corresponding DNA 
oligos in repairing chromosomal GFP 
To accomplish DSB repair on human chromosomal DNA and restore a functional GFP 
gene, the RNA tract of the RNA-containing oligos must be used as a template. The 
appearance of the sequence with the BssHII site carried on the RNA tract in the genome 
of human green fluorescent cells suggests that the RNA-containing oligos are 
participating directly in the repair of GFP. Human cells contain abundant sources of 
reverse transcriptase activity, including LINE1 and L1 elements [90, 108]. Thus, 
considering the large quantity of RTs, it is not realistic to eliminate all RT sources present 
in the human cells. To show that the RNA-containing oligos can directly transfer 
information to chromosomal DNA in human cells without being first reverse transcribed 
into a cDNA molecule, we set up an experiment to determine if the RNA-containing 
oligos displayed a strand-biased repair of the chromosomal GFP. The DNA-only oligo 
spanning the sequence of the GFP sense strand (GFP.D) was always more efficient at 
repairing the chromosomal DSB in GFP than the complementary oligo comprising the 
GFP antisense sequence (GFP.D comp) (Figure 2.5). The bias did not depend on the 
quality of the oligos, as it reproduced even with different oligo preparations ordered from 
different companies (not shown). Moreover, the bias was observed only when the oligos 
were correcting the chromosomal broken GFP since no bias was revealed when the same 
oligos (GFP.D and GFP.D comp) were correcting the broken GFP on the plasmid (see 
below section 2.4.4). It remains unknown if the sense strand of the chromosomal GFP 
corresponds to the lagging strand, as the GFP locus was randomly integrated in the 
human genome and the site of integration was not determined [101]. In light of the 
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observed strand bias in the chromosomal targeting by single-stranded DNA oligos, we 
envisioned that if cDNA intermediates were formed following reverse transcription of the 
RNA-containing oligos, the observed bias of GFP repair by RNA-containing oligos 
would be opposite to that obtained with the corresponding DNA oligos, or there would be 
no bias if the DNA copies were double stranded. As shown in Figure 2.5, GFP targeted 
repair by the RNA-containing oligos displayed the same strand bias as the corresponding 
DNA-only molecules. Two clones cut by BssHII derived from cells targeted by the DNA-
only oligo GFP.D comp and three clones cut by BssHII derived from cells targeted by 
GFP.R6 comp were sequenced and contained no other additional mutations beyond the 
expected BssHII site (data not shown). Thus, it appears that the RNA-containing oligos 
are not copied by an RT function into cDNA before transferring the information to 
chromosomal DNA in human cells. We conclude that human cells have the ability to use 













Figure 2.5 Strand-bias targeting to broken chromosomal GFP in human cells. 
Frequencies in Log scale of human GFP
+
 cells repaired by the DNA oligos (blue bars) or 
the RNA-containing oligos (red bars) per 50,000 transfected cells; median and range are 
shown. Except for the „Cells‟ sample, the „No oligo‟ and the „Oligos‟ samples were 
transfected together with the plasmid expressing the I-SceI endonuclease. A sketch of 










2.4.4. RNA-mediated plasmid repair in human cells 
In order to test if the RNA-containing oligos were proficient at DSB repair also on 
extrachromosomal elements in human HEK-293 cells, we designed an experiment to 
examine the frequency of DSB repair on a plasmid. A plasmid construct (pA568) with 
the GFP gene interrupted by the I-SceI site [101], the same gene sequence as the one 
integrated in the genome of the 658D cell line, was linearized in vitro by restriction 
digestion with the I-SceI endonuclease (New England Biolabs, Ipswich, MA). The 
gapped vector was then cotransfected in the HEK-293 cells together with different RNA-
containing oligos or control DNA oligos. As shown in Figure 2.6, frequencies of GFP 
repair obtained with oligos GFP.R6 and GFP.R6 comp were about 10-fold less than those 
obtained with the corresponding DNA oligos (GFP.D and GFP.D comp). Although some 
strand bias was observed as well when the oligos repaired the broken GFP on the 
plasmid, it was not statistically significant. It is possible that the sequence context or the 
chromatin structure may differently affect chromosomal targeting by single-strand oligos 
from plasmid targeting. We also excluded the possibility of DNA contamination in our 
RNA-driven plasmid correction assay by demonstrating alkaline lability for oligo 
GFP.R6 (Figure 2.3B).  
 
The 80-mer DT_GFP.R has an RNA-only homologous region and a non-homologous 20-
nt DNA flap at the 3‟ end. When it was cotransfected with gapped pA658, it could also 
serve as a template to repair the break and restore the correct sequence of the GFP gene 
in the HEK-293 cells, although it was  ~ 100-fold less efficient than the DNA-only 80-
mers GFP80.D and GFP80.D comp (Figure 2.6). We had to use 5-fold more oligo 
 46 
GFP80.R (up to 10 g) to obtain a detectable number of GFP
+
 cells comparable to that 
obtained with oligo DT_GFP.R, which, in addition, contained an RNA stretch of 
homology to GFP shorter than the GFP80.R (Figure 2.6 and Table 2.1). It is likely that 
the DNA tail of oligo DT_GFP.R could in part prevent end-degradation of the RNA tract 
by exoribonucleases, which have a major role in RNA surveillance [109]. Overall, these 
data suggest that the RNA-containing oligos can transfer information not only to genomic 




















Figure 2.6 Plasmid DNA modifications mediated by RNA-containing oligos in 
human cells. Frequencies in Log scale of human GFP
+
 cells repaired by the DNA oligos 
(blue bars) or the RNA-containing oligos (red bars) per 50,000 transfected cells; median 
and range are shown. Except for the „Cells‟ sample, the „No oligo‟ and the „Oligos‟ 
samples were transfected together with the linearized pA568 plasmid. A sketch of 













Not long ago, it was considered that the major role played by RNA was to carry genetic 
information for protein translation. At present, we know that many RNAs are not used to 
make protein. Non-coding RNAs like small interfering RNAs, microRNAs and Piwi-
interacting RNAs have emerged as fine control tools, which are important for the 
regulation of transcription and translation [110]. Although an astonishing variety of RNA 
functions have been found in the last few decades, it has always been very difficult to 
determine if any RNA has the capacity to genetically modify the DNA of cells. In this 
study we show that the ability of RNA to transfer genetic information to DNA is not 
limited to the yeast system in which the phenomenon was first discovered. By using 
RNA-containing oligos, we have found that RNA can function as a template for DNA 
synthesis without being reverse transcribed into cDNA, not only in yeast but also in E. 
coli and in the human HEK-293 cells. These findings establish that a direct flow of 
genetic information from RNA to DNA can occur in organisms as diverse as bacteria and 
humans, and thus, it can be a significant source of genetic variation.  
 
How likely is the flow of information directly from RNA to genomic DNA without any 
specific reverse transcriptase function and without the requirement of any cDNA 
intermediate? Unexpectedly, as mentioned above, there are an increasing number of 
reports supporting the concept that RNA could guide genetic alterations. Moreover, there 
is a rising amount of evidence indicating that ribonucleotides can be incorporated into 
DNA during DNA synthesis and replication ([111] and references therein) and could thus 
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form hybrids with DNA. It is also possible that short RNA tracts are incorporated in 
DNA following primase inclusion of deoxyribonucleotides in addition to ribonucleotides 
in the primer sequence [8, 9]. It is worth noticing that ribonucleotides in DNA can distort 
the double helix [11, 112] and can form quite stable duplexes with DNA if enriched in 
ribonucleotide G [113]. It is however not known to what extent such RNA/DNA hybrids 
can be tolerated in DNA and to what level these hybrids can affect the genetic integrity of 
cells.  
 
Interestingly, it has been postulated that the flow of information from RNA to DNA 
could lead to DNA recoding events in the nervous system that could be the basis for 
permanent storage of long term memories [114, 115]. Yet, the molecular mechanisms by 
which RNA could repair or edit DNA in neuronal cells are not known.  
 
The goal of future research is to understand the mechanisms by which RNA can directly 
transfer information to the DNA of cells and to reveal the circumstances in which RNA 
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Generation of RNA/DNA hybrids in genomic DNA by transformation 
using RNA-containing oligonucleotides 
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Synthetic short nucleic acid polymers, oligonucleotides (oligos), are the most functional 
and widespread tools of molecular biology. Oligos can be produced to contain any 
desired DNA or RNA sequence and can be prepared to include a wide variety of base and 
sugar modifications. Moreover, oligos can be designed to mimic specific nucleic acid 
alterations and thus, can serve as important tools to investigate effects of DNA damage 
and mechanisms of repair. We found that Thermo Scientific Dharmacon RNA-containing 
oligos with a length between 50 and 80 nucleotides can be particularly suitable to 
study, in vivo, functions and consequences of chromosomal RNA/DNA hybrids and of 
ribonucleotides embedded into DNA. RNA/DNA hybrids can readily form during DNA 
replication, repair and transcription, however, very little is known about the stability of 
RNA/DNA hybrids in cells and to which extent these hybrids can affect the genetic 
integrity of cells. RNA-containing oligos, therefore, represent a perfect vector to 
introduce ribonucleotides into chromosomal DNA and generate RNA/DNA hybrids of 
chosen length and base composition. Here we present the protocol for the incorporation 
of ribonucleotides into the genome of the eukaryotic model system yeast Saccharomyces 
cerevisiae. Yet, our lab has utilized Thermo Scientific Dharmacon RNA-containing 
oligos to generate RNA/DNA hybrids at the chromosomal level in different cell systems, 










Exploiting the use of Thermo Scientific Dharmacon oligos, 50 to 80-mers, here we 
present a procedure, based on a gene correction assay, by which oligos can transfer 
genetic information to genomic DNA of yeast cells, following annealing to the target 
chromosomal DNA. Successful targeting by oligos is scored by the appearance of yeast 
colonies displaying the expected phenotype. If the desired genetic modification is carried 
within one or more ribonucleotides incorporated in the oligo sequence, the genetic 
information flows directly from the RNA tract to the chromosomal target DNA, thus, an 
RNA/DNA hybrid forms at the chromosomal level during the targeting process. The 
ribonucleotide/s of a Thermo Scientific Dharmacon RNA-containing oligo can serve as 
template for gene targeting via DNA repair synthesis or can be embedded into the DNA 
and serve as template during DNA replication. In these experiments we use the yeast 
Saccharomyces cerevisiae eukaryotic model system; however, a similar approach can 
also be applied in other organisms or cell types. In this video, we use a Thermo Scientific 
Dharmacon oligo designed with homology to a target yeast genomic locus and containing 
one ribonucleotide in the middle to correct a mutation in the target gene. After 
transformation with the RNA-containing oligo, we observe the correction of the targeted 
site at a certain frequency, which indicates that the RNA tract of the oligo could be 
incorporated into the chromosomal DNA and serve as template for DNA synthesis during 
DNA replication. The genetic information carried within the RNA tract is stably 
transmitted to the following cell generations. Here we describe the steps of yeast cell 
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transformation by the Thermo Scientific Dharmacon RNA-containing oligo and the 
approach to detect the RNA information transferring into chromosomal DNA. 
3.2.2. Design of the RNA-containing Oligo used in this Experiment 
We have designed an RNA-containing oligo to correct a genetic defect in the yeast S. 
cerevisiae chromosomal DNA at the trp5 locus. The yeast strain used in the protocol 
contains a mutant trp5 gene with a two-base deletion and one nonsense mutation (Figure 
3.1A). Such yeast strain is a tryptophan auxotrophic mutant and does not form colonies 
on media without tryptophan. The DNA sequence of the TRP5 gene is available at the 
Saccharomyces Genome Database (http://www.yeastgenome.org/). The Thermo 
Scientific Dharmacon RNA-containing oligo used in this protocol is a 65-mer with a 2-
base DNA insertion, designed to correct the deletion mutation and one ribonucleotide 
designed to correct the nonsense mutation of the trp5 allele (Figure 3.1A). The sequence 
of the oligo is designed as follows: 
5'-AAAAGGGTTTTGATGAAGCTGTCG-CG-GATCCCACATTCTG-rG-
GAAGACTTCAAATCCTTGTATTCT. This oligo is synthesized by Thermo Scientific 
Dharmacon (Lafayette, CO) at 200 nM scale, and is desalted, deprotected and used 
without PAGE purification. 
3.2.3. Preparation of the RNA-containing Oligo for Yeast Transformation (modified 
from Storici et al., 2007 [77]) 
1. Wipe materials that will be used for the experiment including oligo tubes, 
pipettes, vortex, racks, experimental area and gloves worn by the investigator with 
RNase decontamination solution to remove potential RNase contamination before 
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everything starts. Use RNase-free water, chemical reagents, tubes and pipette tips 
in all steps. Every step in this experiment should be RNase-free. 
2. Resuspend the Thermo Scientific Dharmacon RNA-containing oligo received 
from the company to 250 pmoles/μl stock solution with RNase-free water and 
vortex vigorously to dissolve the pellet. Store at -80°C. 
3. Immediately before the transformation, thaw the RNA-containing oligo on ice and 
dilute to 50 pmoles/μl with RNase-free water in RNase-free tubes. Each 
transformation requires 1 nmole of the RNA-containing oligos. 
4. Denature a chosen amount of the RNA-containing oligos on the 100 °C heat block 
for 2 min to eliminate secondary structures of the oligos. 
5. Immediately after denaturation place the tube on ice. Keep on ice till 
transformation. 
6. As control in the experiment a corresponding DNA-only oligo is used. This oligo 
is thawed from -20 °C and prepared for the transformation as the RNA-containing 
oligo, as described above. 
3.2.4. Transformation of Yeast Cells using the RNA-containing Oligo 
1. Inoculate 5 ml of rich YPD liquid medium with the trp5 mutant yeast cells and 
grow at 30 °C overnight (see Materials). 
2. Transfer 1.5 ml of the overnight culture into 50 ml of YPD liquid medium. 
3. Incubate cells in a 30 °C shaker (225 rpm) for 4h. 
4. Prepare Solution 1 and Solution 2 immediately before transformation in RNase-
free tubes (see Materials). 
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5. Transfer the cell culture to a 50 ml RNase-free tube and spin at 3000 rpm, 




6. Remove the supernatant and wash cells with 50 ml of RNase-free water and spin 
at 3000 rpm for 2 min. 
7. Repeat step 6 for 5 times to get rid of the culture medium and RNases that could 
be present in the medium as much as possible. 
8. Remove the supernatant and resuspend cells in 5 ml of Solution 1 and spin at 
3000 rpm for 2 min. 
9. Remove supernatant and resuspend cells in 250 μl of Solution 1. This amount of 
cells is sufficient for 7-8 transformations. 
10. Aliquot 50 μl of the cell suspension in RNase-free microcentrifuge tubes, add 20 
μl of RNA-containing oligo working solution (1 nmole), or 20 μl of DNA-only 
oligo working solution (1 nmole), or 20 μl of sterile water with no oligo for the 
negative control. Then add 300 μl of Solution 2 for each transformation reaction. 
There is no need to add salmon sperm DNA in the process of transformation, as 
the oligos act as carrier themselves. 
11. Vortex vigorously to mix components homogenously. 
12. Incubate transformation reactions at 30 °C for 30 min in a shaker. 
13. Heat shock at 42 °C for 15 min. 
14. Spin down cells at 5000 rpm, corresponding to 2236 g, for 4 min. 
15. Remove supernatant and resuspend cells in 100 μl of sterile water. 
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16. Take an aliquot of this cell suspension and dilute it with sterile water by 100,000 
fold and plate cells on one YPD plate using approx. 15 sterile glass beads and 
incubate at 30 °C for 2 days. 
17. Plate all resuspended cells from each transformation reaction on one Petri dish of 
synthetic complete solid medium without tryptophan (SC-Trp) using approx. 15 
sterile glass beads and incubate at 30 °C for 4-5 days (Figure 3.2). 
3.2.5. Analysis of Gene Correction by the RNA-containing Oligo 
1. Count the number of colonies grown on the selective medium (Figure 3.2) as well 
as on YPD medium to calculate the gene correction frequency for the RNA-
containing oligo, the DNA-only oligo and for the no-oligo control. Compare the 
number obtained. Spontaneous reversion rate of the trp5 alleles with the two-base 
deletions and the nonsense mutation is less than 10
-9
 in the used yeast strain, thus 
we expect no colonies formation on the selective medium when no oligos are 
added to the cells. 
2. Streak out several randomly picked transformant colonies onto YPD medium to 
obtain single colony isolates. Wait two days for colony growth, then take several 
(at least 5) single colonies and make patches on YPD and on selective medium. 
3. Design a pair of primers to amplify the region (250-1,000 bp) targeted by the 
RNA-containing oligo by colony PCR (Figure 3.1B). The procedure for colony 
PCR is as follows (modified from Storici and Resnick, 2006 [116]). 
1. Resuspend cells (approx. 1 mm3) taken from the individual patches in 50 
μl of water and add 1 unit of lyticase. Incubate at room temperature for 10 
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min, followed by incubation in a heat block at 100 °C for 5 min to break 
the cells and release genomic DNA in solution. 
2. PCR conditions: The PCR reaction includes 10 μl of the cell resuspension 
solution, 50 pmoles each of forward and reverse primers, 1 μl of 10 mM 
dNTPs, 1 unit of Taq polymerase, 5 μl of 10x buffer and is adjusted with 
sterile water to a final volume of 50 μl. The PCR program is 3 min at 95 
°C; 30 cycles of 30 s at 95°C, 30 s at 55 °C, and 1 min at 72 °C; a final 
extension time of 7 min at 72 °C; then samples are kept at 4 °C. An 
extension time of 1 min/kb is assumed for this reaction. 
3. Following PCR, samples are run on a 1% or 2% (depending on the 
expected size of the PCR product) agarose gel for observation of the PCR 
product (Figure 3.3). 
4. If the genetic information transferred by the RNA-containing oligo generates a 
new restriction site in the yeast genomic target region (Figure 3.1B), it is possible 
to verify the correct transfer of information by digesting the PCR product with the 
appropriate restriction enzyme. If no restriction site is generated by the RNA-
containing oligo, go to step 6. Digest PCR products using a specific restriction 
enzyme. The digestion reaction includes 6 μl of PCR product, buffer, BSA (may 
not be needed for some enzymes, see instruction for the enzyme used), 0.5 μl of 
restriction enzyme, and sterile water to 15 μl. Samples are incubated for 1 h at the 
temperature specific for the enzyme used. 
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5. Run an undigested sample together with the digested samples on the same row of 
a 2% agarose gel to observe the genetic modification transferred by the RNA tract 
of the RNA-containing oligo (Figure 3.3). 
6. Purify PCR products by using a PCR purification kit and prepare them for DNA 
sequencing. Submit samples for sequencing with the same primers used to 
amplify the product. 
7. Analyze DNA sequencing results using software that allows alignment of multiple 
sequences with a chosen reference sequence (Figure 3.4). 
3.2.6. Alkali Treatment of the RNA-containing oligo (Figure 3.5) 
1. For each reaction, add 1 nmole (4 μl of 250 pmoles/μl stock solution) of the 
RNA-containing oligo, or DNA-oligo into a 1.5 ml tube. 
2. Add 4 μl of 1 M NaOH for hydrolysis, or alternatively add 4 μl H2O as negative 
control, and incubate at 65° C in a water bath for 1 h. Then move from the water 
bath to ice. 
3. Neutralize with 2 μl of 1.2 M HCl, 4 μl of 1 M Tris-HCl, and 4 μl of H2O, or 
alternatively 6 μl of H2O and 4 μl of 1 M Tris-HCl for negative control. Keep on 






3.3.1. Transformation reagents and media (modified from Storici and Resnick, 2006 
[116]) 
1. YPD (Yeast Peptone Dextrose): For 1 L, 10 g yeast extract, 20 g soy peptone, 20 
g dextrose. Add 15 g agar to make YPD solid media. Autoclave before use. Store 
at room temperature. 
2. Solution 1: 0.1 M of lithium acetate. Prepare immediately before transformation. 
Solution 1 is a working solution, thus it is prepared directly from the powder. No 
stock solution is made. Keep at room temperature. LiAc increases the yeast cell 
wall permeability to DNA. 
3. Solution 2: 0.1 M of lithium acetate and 50 % of polyethylene glycol 4000. Also 
solution 2 is a working solution and it is made directly from the powder. No stock 
solution is prepared. Keep at room temperature. PEG deposits oligos onto yeast 
cells. 
4. RNA-containing oligos (Thermo Scientific Dharmacon), 50-80-mers, desalted, 
deprotected and non-purified. Resuspend to 250 pmoles/μl. Store at -80°C. 
5. DNA-only oligos, 50-80-mers, desalted and non-purified. Resuspend to 50 
pmoles/μl. Store at -20°C. 
6. SC-Trp (Synthetic complete media lacking tryptophan) solid media. 
7. 0.5 cm diameter glass beads, sterilized by autoclaving. 
8. RNase-off: RNase decontamination solution. 
9. DNase/RNase-free, sterile centrifuge tubes. 
10. DNase/RNase-free, sterile conical tubes. 
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11. DNase/RNase-free, sterile aerosol pipette tips with ZAP: 1-200 ml, 100-1000 ml. 
3.3.2. Colony PCR materials. 
1. DNA primers, desalted and non-purified. Dissolve in sterile water to 50 
pmoles/μl. Store at -20°C. 
2. Taq DNA polymerase, buffer, dNTPs. 
3. PCR tubes. 
3.3.3. PCR purification. 
1. PCR purification kit. 
3.3.4. Gel Electrophoresis. 
1. Agarose. 
2. 1 x TBE running buffer (45 mM Tris-borate and 1 mM ethylenediamine 
tetraacetate) diluted from 10x TBE. 
3. Prestained molecular weight marker. 
4. DNA loading dye. 
3.3.5. Restriction digestion. 
1. Restriction enzymes, 10x buffers, BSA. 
3.3.6. Alkali treatment for the RNA-containing oligo. 
1. 1 M of NaOH solution. 
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2. 1.2 M of HCl solution. 




















Figure 3.1 Schematic diagram of the defective trp5 gene and of the TRP5 allele 
corrected by the RNA-containing oligo. A) The trp5 mutant gene contains a 2-base 
deletion (black triangles) and 1-base nonsense mutation (asterisk). The single-strand 
RNA-containing oligo with 2-base insertion (blue loop) and 1-RNA base substitution (red 
rectangle) generating a Van91I restriction enzyme site (shown by the bracket) is 
transformed into yeast cells to correct the genetic defects of the trp5 gene. B) After the 
TRP5 gene is repaired by the RNA-containing oligo (corrected bases are indicated as blue 
rectangles), the Van91I site is generated into the TRP5 gene. A 278 bp fragment 
including only one Van91I restriction site in TRP5 gene is PCR amplified by a pair of 
primers (P1 and P2). The 177 bp and 101 bp fragments generated after digestion of the 









Figure 3.2 Transformation result with the RNA-containing oligo. A) Yeast cells 
transformed with no oligo do not form any colony on the SC-Trp medium, see plates a-b. 
B) Plates c-g show yeast colonies growing on SC-Trp after cells are transformed with 1 
nmole of the RNA-containing oligo. C) Plates h-l show yeast colonies growing on SC-

















Figure 3.3 Detection of genetic information transfer from the RNA-containing oligo 
to yeast chromosomal DNA by restriction digestion of the PCR product amplifying 
the targeted genomic region. 2% agarose gel electrophoresis of PCR samples amplified 
by P1 and P2 and digested with Van91I restriction enzyme. Lanes 1, 8 and 15, DNA 
ladder with sizes of 100, 200, 300, 400 and 500 bp indicated on the left; lane 2, PCR 
product of trp5 locus amplified from the genomic DNA of the trp5 mutant strain; lane 3, 
PCR product amplified from genomic DNA derived from a Trp
+
 colony targeted by the 
DNA-only oligo; lane 4-7, PCR products amplified from genomic DNA derived from 
Trp
+
 colonies targeted by the RNA-containing oligo; lane 9 to 14, Van91I restriction 
digestion of the PCR products from lanes 2 to 7. The presence of the uncut PCR product 
bands in lanes 10 to 14 can be explained by partial digestion by Van91I at the TRP5 locus 
(CCACATTCTGG). Considering that the cutting site for Van91I (CCANNNN‟NTGG) 
can have multiple sequences, the site generated in TRP5 may not be the most optimal 
target for the enzyme. In fact, following DNA sequencing of all the above PCR products 
we detect no additional changes beyond those carried by the oligos (see Figure 3.4). The 
278 bp PCR band amplified by P1 and P2 primers and the digestion product bands by 












Figure 3.4 DNA sequencing results showing gene correction by the RNA-containing 
oligo. A) DNA electropherogram of the genomic region targeted by the RNA-containing 
oligo. The G in the DNA sequence (blue boxed) derives from the rG on the RNA-
containing oligo. Also boxed is the insertion of the CG bases. Sequencing results from all 
other PCR products are also as clear as this one, with fluorescent signals well above the 
background. B) Sequences of the TRP5 region of the Trp
+
 transformants targeted by the 
DNA-only oligo (T1) and the RNA-containing oligo (T2-T5) match in the consensus 
sequence on the top and are compared with that of the trp5 mutant cells before targeting 
by the oligos (Genomic DNA, red shaded). The repair RNA-containing oligo on the 
bottom has two-base DNA insertion and one-base (G) RNA substitution marked in red. 
The regions boxed in blue with yellow shade show that the RNA-containing oligo as well 
as the DNA-only oligo precisely corrected the deletion mutation and nonsense mutation 


















Figure 3.5 Alkali treatment prevents gene correction by the RNA-containing oligo. 
The transformation frequency by the RNA-containing oligo (R) is shown in the red bar 
and that by the DNA-only oligo (D) is shown in the blue bars. The error bars represent 
the standard deviations of the data for 3 independent transformations for each oligo. The 
DNA-only oligo displays similar transformation frequency without and with NaOH 
treatment. Differently, transformation frequency by the RNA-containing oligo drops to 
<0.1 following treatment with NaOH. Therefore, the preparation with the RNA-
containing oligo is not contaminated with DNA-only oligo, thus, the observed 






The fact that RNA can transfer genetic information directly to genomic DNA in cells was 
discovered exploiting the use of synthetic RNA-containing oligos (Dharmacon 
synthesized oligos) [77]. It was the proof of principle that cells can use RNA-containing 
molecules or RNA-only sequences as templates for DNA synthesis. The use of RNA-
containing oligos not only led to the demonstration that genetic information can be 
transferred directly from RNA to genomic DNA without the need of a reverse transcribed 
DNA copy intermediate, but also to the proof that RNA can be used as homologous 
template in the repair of a DNA damage [77, 91]. The oligos can be made of RNA-only 
or contain just a single ribonucleotide embedded in a DNA sequence, as in the example 
we presented here. The RNA-containing oligo has one embedded ribonucleotide designed 
to correct the nonsense mutation in the genomic defective trp5 allele. The transfer of 
genetic information from the ribonucleotide to the genomic DNA is revealed by a change 
in phenotype (cell growing on the medium lacking tryptophan) of the targeted cells. The 
frequency of gene correction obtained with the RNA-containing oligo is measured and 
compared with that of a control DNA-only oligo. By performing this gene correction 
assay in different cell backgrounds, where we mutate various yeast genes, we can detect 
which factor/s specifically affect targeting by the RNA-containing oligos. Thus, we can 
reveal mechanisms how cells regulate the stability of RNA/DNA hybrids. By simply 
designing different variants of the RNA-containing oligos we can determine the 
likelihood for a particular RNA tract to serve as template in DNA modification and we 
can determine the stability of specific RNA sequences embedded into DNA. Moreover, 
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we can identify what are the preferred in vivo substrates for factors interacting with 
RNA/DNA hybrids. 
 
While several in vitro studies, mainly utilizing short RNA-containing oligos, have been 
conducted to characterize the function of factors that can recognize RNA in a hybrid with 
DNA, such as the RNase H enzymes [20], the in vivo functions of RNases H as well as 
the identity of other proteins that could affect RNA/DNA hybrid stability remain mostly 
unknown. The possibility to utilize RNA-containing oligos of a significant length (50 to 
80-mers) and optimal quality (such as Thermo Scientific Dharmacon RNA-containing 
oligos) has open the way to examining a wide range of molecular processes directly in 
vivo in the cells of interest. As shown in this video, transformation using RNA-containing 
oligos requires essentially only a few additional steps compared to transformation using 
DNA molecules, to prevent degradation by RNases. Thus, transformation using RNA-
containing oligos is not limited to the yeast system, but can be applied to any organism or 
cell type where transformation by DNA oligos is proficient. 
 
In conclusion, targeting cells by RNA-containing oligos provides the opportunity to 
generate RNA/DNA hybrids and ribonucleotides embedded in DNA in vivo in cells. The 
stability, function and consequences of these in vivo generated RNA/DNA hybrids can be 
analyzed and characterized, potentially uncovering unknown mechanisms of DNA repair 














Mispaired rNMPs in DNA are mutagenic and are targets of 
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Numerous studies have shown that ribonucleoside monophosphates (rNMPs) are 
abundant among all non-standard nucleotides occurring in genomic DNA. Therefore, it is 
important to understand to what extent rNMPs may alter genome integrity and what 
factors affect their stability. We developed oligonucleotide-driven gene correction assays 
in the bacterium Escherichia coli and the yeast Saccharomyces cerevisiae to show that 
mispaired rNMPs embedded into genomic DNA, if not removed, serve as templates for 
chromosomal DNA synthesis and produce a genetic change. We discovered that isolated 
mispaired rNMPs in chromosomal DNA are removed by the mismatch repair system in 
competition with RNase H type 2. However, a mismatch within an RNA/DNA 
heteroduplex region requires RNase H type 1 for efficient removal. In the absence of 
mismatch repair and RNase H functions, ribonucleotide-driven gene modification 

















Modifications of nucleotides in DNA pose a threat to the genomic integrity of cells, 
often resulting in cell death or mutation. Numerous studies suggest that 
ribonucleoside monophosphates (rNMPs) are abundant among all non-standard 
nucleotides occurring in genomic DNA. Many DNA polymerases have been shown 
in vitro to incorporate rNMPs into DNA [117-122], including all yeast replicative 
polymerases [123]. Importantly, the combination of ribonucleotide misincorporation 
and mispairing in vivo can occur with sufficient frequency to affect mutation rates in 
yeast [111, 124]. The finding that rNMP incorporation during replication in yeast is 
coupled with genome instability in an RNase H2 defective background [111] raises 
the question whether mismatches generated by mispaired rNMPs or processing of 
rNMPs in DNA are subject to mismatch repair (MMR).  
 
The concentration of ribonucleoside triphosphates in cells is generally higher than that of 
deoxyribonucleoside triphosphates, increasing the probability of paired and mispaired 
rNMP incorporation by DNA polymerases during DNA replication and repair ([123] and 
references therein). Regions of highly transcribed DNA were found to contain a high 
concentration of dUMP in yeast [7], and it would be interesting to see if these regions 
may also be hot spots for rNMP incorporation. In addition, DNA primases have very low 
fidelity, resulting in the incorporation of mispaired rNMPs, and could potentially leave 
one or several rNMPs embedded in chromosomal DNA by including 
deoxyribonucleotides in addition to ribonucleotides in the primer sequence [8, 9]. Finally, 
oxidative damage of DNA can convert a deoxynucleotide in DNA to an rNMP [10].  
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Ribonucleotides in DNA can distort the double helix [11], resulting in genomic 
instability, defective replication [112] or transcription and mutagenesis. Topoisomerase I 
can initiate a process of rNMP removal when its site of cleavage occurs 3‟ to an rNMP 
embedded in DNA [125]. However, the enzymes that specifically cleave RNA in 
RNA/DNA hybrids are ribonucleases H (RNase H type 1 (I or 1) and type 2 (II or 2)) [20, 
126]. In vitro, RNases HI/1 and RNases HII/2 have very distinct cleavage patterns. 
RNases HI/1 require a substrate with an RNA stretch containing at least four 
ribonucleotides in a DNA duplex to allow cleavage, while RNases HII/2 can cleave a 
single ribonucleotide embedded in DNA even when mispaired [20, 23]. Yet, up to now a 




















4.3. MATERIALS AND METHODS 
 
4.3.1. Bacterial strains. All E. coli strains used here (Table A.1a) have a 
thermoinducible  red recombination system, which permits the efficient incorporation of 
linear DNA into the chromosome [100]. Because both RecB and RecC are required for 
the viability of an rnhA mutant [127], we deleted the prophage N-gam segment [100], the 
product of which is an inhibitor of the RecBCD enzyme [128]. The partially deleted 
prophage retained functional exo and bet genes of the  red region, of which only the bet 
gene is necessary for oligo transformation [100]. Transductions were performed with 
bacteriophage P1 dam rev6 [129]. We used both deletion and nonsense mutations for 
rnhA and rnhB. Complete deletions of the coding regions are ideal because they eliminate 
the possibility that defective products might still be present, although they also remove 
the promoters of neighboring dnaQ and dnaE genes, which then are transcribed, we 
assume, from alternative promoters. Therefore, we also constructed truncated forms of 
RNase HI and HII (verified by sequencing) by introducing two consecutive stop codons 
(Ochre and Opal) upstream of dnaQ and dnaE promoters and after codon 48 in rnhA and 
after codon 70 in rnhB in strain BW1988 and BW2037 exploiting oligo-directed 
transformation (Table A.1a). We then compared the transformation frequencies by the 
LacZ.R6I2, LacZ.R1S1 or LacZ.D oligo in the rnh deletion and nonsense mutants and no 
differences were revealed (Table A.6a, b). We concluded that both the deletion and 
nonsense rnh mutant alleles behave similarly, at least with respect to gene correction by 
RNA-containing oligos. The mutS::gm mutation was replaced in some strains by the 
mutS
+ 




and mutS transductants were scored by the relative frequency of 
spontaneous mutation to streptomycin resistance. Bacterial media and growth conditions 
were as described before [130].  
 
4.3.2. Yeast strains. The yeast haploid strains used in this work derives from FRO-694, 
which contains the GSKU cassette [65] and the I-SceI cutting site in TRP5, inserted 
between nucleotide (nt) C1001 and nt C1002 (Table A.1b). Three different oligos with 
homology to the TPR5 gene containing a 2-base deletion ( C-C1001-1002) plus a 
nonsense mutation (nt G1017 to A), only the 2-base deletion mutation, or only the 
nonsense mutation were used to transform the FRO-694 to pop out the GSKU cassette in 
trp5 and generate the three different trp5 alleles in three different strains, YS-301/303, 
YS-316/318 and YS-320/322, respectively (Table A.1b), following the “delitto perfetto” 
method as described [65]. The oligos used for the construction of the different trp5 alleles 
are shown here with the introduced mutations in bold:  
80DeltaCC+STOP_TRP5.e:  
5'-AAGAGAGTTGGAAAAGGGTTTTGATGAAGCTGTCG__GATCCCACATTCTG 








AGAAGACTTCAAATCCTTGTATTCTTATATT (nonsense mutation). 
Null alleles for RNH201, MSH2 or both were created by replacing the open reading frame 
of each of these genes by either the kanMX4 or the hygMX4 module.  
 
4.3.3. Transformation using oligos. For experiments in E. coli, electrocompetent cells 
were prepared as described [99] and used immediately. The final wash and resuspension 
were in RNase-free water. RNA-containing oligos retained ≥90% of their activity after 
incubation with fresh cells for 3 min. Electroporation was performed as described [99], 
immediately after adding 100 ng of oligo in 50 l of a cell suspension. For transformation 
experiments to mutate the rpsL
+
 gene, 10 l of cultures after recovery in the SOC media 
were transferred to 1 ml of LB media and incubated overnight to reduce the proportion of 
the original streptomycin-sensitive ribosomes. Cells were then diluted in 10 mM MgSO4 
and plated in an overlay of 4 ml of soft agar on LB agar with streptomycin to select for 
transformants and on LB agar to measure viability. Survival after transformation was 
24%-30% for BW1988, BW2037 and all the derivative strains used. All strains with rnhA 
mutations form smaller colonies on LB agar media than strains with wild-type rnhA. For 
experiments in yeast, transformation with RNA-containing or DNA-only oligos (1 
nmole) were done as described [77]. Cells from each oligo transformation were plated to 
selective Trp
-
 media and were diluted and plated on the rich YPD media. Survival after 
yeast transformation was 29% for WT, 26% for msh2, 24% for rnh201 and 29% for 
rnh201 msh2 cells, respectively. The relative transformation frequencies were calculated 
by dividing the number of transformants per 10
7
 viable cells obtained with an RNA-
containing oligo by the median of the number of transformants per 10
7
 viable cells 
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obtained with the corresponding DNA-only oligo in the same experiment. The results are 
each expressed as a median and 95% confidence limits (in parentheses), or alternatively 
the range when number of repeated experiments was <6. Random clones derived from 
gene correction by LacZ.R1S1 in the rnhB mutS background, LacZ.R5S1 in the rnhA rnhB 
background, RpsL.R1S1 in the rnhB mutS background, or TRP5.R2_R1I2_S1 in the rnh201 
msh2 background were sequenced at the region targeted by the oligos, and all (24/24, 




, or TRP5 
sequence, with no additional changes. 
 
4.3.4. Alkali treatment of oligos. Two l of a 10 g/ l solution for RNA-containing or 
DNA only oligos were treated before the transformation experiments in E. coli with 2 l 
of 1 M NaOH at 65° C for 1 h, and then neutralized with 0.2 l of 1 M HCl and 0.8 l of 
1 M Tris-HCl pH 7.4, and H2O was added to 100 l. Alternatively, 2 l of the same 
RNA-containing or DNA-only oligo solutions were treated with 2 l of H2O at 65° C for 
1 h, and then neutralized with 2 l of H2O and 0.8 l of 1 M Tris-HCl pH 7.4, and H2O 
was added to 100 l. Alkali treatment of oligos for experiments in yeast was performed 
as described [77]. 
 
4.3.5. Standard genetic and molecular biology techniques. Standard genetics and 
molecular biology analyses were done as described [65, 77, 99]. Samples for sequencing 
were submitted to Eurofins MWG Operon, (Huntsville, AL). 
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4.3.6. RNase HII cleavage assay. RNA-containing oligos and their corresponding DNA-
only oligos (Table A.2) were 5‟-end-labeled using [γ-32P]ATP (PerkinElmer, Waltham, 
MA) and T4 Polynucleotide Kinase (NEBioLabs, Ipswich, MA). Double-stranded 
substrates (Figure 4.2) were prepared by annealing appropriate complementary oligos in 
1X ThermoPol Reaction Buffer (NEBioLabs), which is the RNase HII reaction buffer, at 
pH 8.8. RNase HII reactions were performed by incubating 40 fmol of each substrate 
with 1 unit of RNase HII (NEBioLabs) in the same buffer for 2 hours at 37°C, or with 
0.75 units of RNase HII for 30 minutes at 37°C. 20/100 Oligo Length Standard (IDT, 
Coralville, IW) was used as a marker. Gel electrophoresis was run with a denaturing 15% 
polyacrylamide (19:1) / Urea (8M) gel at 50W with 1X TBE buffer at 50°C. Following 
electrophoresis, gels were exposed to a phosphor screen overnight. Images were taken 
with Typhoon Trio
+
 (GE Healthcare, Piscataway, NJ). Band intensities were quantified 














4.4.1. Impact of RNase HI and RNase HII on gene correction by rNMP-containing 
oligos in mismatch repair defective E. coli 
We initially set up a gene correction assay for different RNA-containing oligonucleotides 
(oligos) in the E. coli strain BW1988, which is an MMR-deficient (mutS null) strain 
expressing the  phage recombination system for highly efficient oligo targeting [99, 
105] (Table A.1a). In this system, lagging-strand oligos anneal to the complementary 
gapped single-strand region at the replication fork, are incorporated into the genome 
similarly to Okazaki fragments and serve as templates for gene correction in the next 
round of DNA replication [105]. A lagging-strand oligo containing a tract of 6 rNMPs 
was also much more efficient at gene correction than the corresponding complementary 
oligo [67]. The E. coli BW1988 strain had a lacZ marker gene altered by a two-base 
frameshift deletion ( GG1370-1) and a missense mutation at nucleotide 1384, changing 
codon GAG (Lac
+
) into AAG (Lac
-
) [99] (Table A.1a). To correct these lacZ mutations, 
BW1988 was transformed with lagging–strand oligos having the sequence of the wild-
type lacZ gene and containing 6 or 2 rNMPs opposite to the deletion (LacZ.R6I2 or 
LacZ.R2.47I2), 1 rNMP or 5 rNMPs opposite to the missense mutation (LacZ.R1S1 or 
LacZ.R5S1), or no rNMPs (LacZ.D or LacZ.D.47) (Figure 4.1a and Table A.2). 
Transformation results are shown in Table 4.1. In the mutS background, differently from 
the LacZ.R6I2 and the LacZ.R2.47I2, the LacZ.R1S1 and the LacZ.R5S1 oligos produced a 
surprisingly low frequency of Lac
+
 transformants relative to the control DNA-only 
oligos. The experiment was repeated with mutants for RNase HI (rnhA) and RNase HII 
(rnhB) in the mutS background to see if the enzymes would affect oligo transformation by 
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attacking the embedded rNMPs. As presented in Table 4.1, the rnhA mutation showed a 





) increase). Differently, the rnhB mutation enhanced the relative transformation 
frequency of the LacZ.R1S1 oligo 6,800-fold (3.43/5*10
-4
) and that of the LacZ.R6I2 oligo 
8-fold (0.16/0.02). It had no effect on the LacZ.R2.47I2 oligo, and it enhanced the 
frequency of the LacZ.R5S1 oligo only in combination with the rnhA mutation. Clearly, 
our data show that in vivo RNase HII very efficiently targets a single mispaired rNMP 
and cannot target the isolated 2-rNMP loop, whereas RNase HI is preferred to RNase HII 
for targeting a tract of 5 rNMPs with a mispair. The stronger resistance of LacZ.R6I2 and 
in particular of LacZ.R2.47I2 to cleavage by RNase HI and HII is probably due to the 
secondary structure of the insertion loop present in these oligo sequences. From in vitro 
studies it is known that RNases HI/1 can cleave DNA substrates containing a stretch of at 
least four ribonucleotides, whereas RNases HII/2 can cleave a single ribonucleotide 
embedded in DNA, even when mispaired, or longer embedded rNMP tracts[20, 23]. It 
was then surprising to find that the rnhB mutation did not affect the gene correction 
frequency by the LacZ.R5S1 and the LacZ.R2.47I2 oligos and it only modestly affected 
that by the LacZ.R6I2 oligo compared to that by the LacZ.R1S1 oligo (Table 4.1). The data 
also demonstrate that all the different rNMPs embedded in double-stranded E. coli 








Figure 4.1 Diagrams and sequences of the E. coli lacZ and rpsL loci and the yeast 
trp5 locus targeted by the RNA-containing oligos. In the name of the RNA-containing 
oligos, substitutions are indicated by a subscript capital “S” and insertions by a subscript 
capital “I”. The letters “S” and “I” are followed by a subscript number indicating the 
number of bases that are substituted or inserted, respectively. (a) The lacZ locus 
containing a two-base deletion and a substitution mutation targeted by the LacZ.R6I2, 
LacZ.R2.47I2, LacZ.R1S1, or LacZ.R5S1 oligo. (b) The lacZ locus containing a substitution 
mutation targeted by the LacZ.R1S1, or LacZ.R5S1 oligo. (c) The rpsL locus targeted by 
the RpsL.R1S1 oligo. (d) The trp5 locus containing a two-base deletion and a substitution 
mutations targeted by the TRP5.R2_R1I2_S1 oligo, (e) containing just a substitution 
mutation targeted by the TRP5.R1S1 oligo, or (f) containing only a two-base deletion 





















Table 4.1 The effect of RNase HI (rnhA) and RNase HII (rnhB) mutations on 
transformation by rNMP-containing oligos in E. coli mutS cells 
Genotype LacZ.R6I2 LacZ.R2.47I2 LacZ.R1S1 LacZ.R5S1 































mutS rnhA rnhB 0.38 (0.35-0.46) ND 2.40 (1.94-2.81)  0.08 (0.06-0.09) 
 
The values are relative frequencies of Lac
+ 
transformants (see Methods). The significance 
of all non-overlapping confidence limit values was confirmed by the Mann-Whitney test 
(P < 0.05) (Table A.3a). The median transformation frequencies per 10
7
 cells and 95% 
confidence limits (in parentheses) for each of the strains with the LacZ.D and the 
LacZ.D.47 oligos were as follows: mutS, 7,290 (4,120-10,800); mutS rnhA, 7,780 (5,090-
11,300); mutS rnhB 4,840 (2,880-6,950); mutS rnhA rnhB, 12,908 (7,750-18,000), and 
mutS, 2,430 (1,770-3,760); mutS rnhB 2,720 (2,250-3,630), respectively. In the absence 
of a transforming oligo, the frequency of Lac
+
 colonies per 10
7
 viable cells were <0.1. 
The numbers of repeats for each of the mutS, mutS rnhA, mutS rnhB, and mutS rnhA rnhB 
strains transformed with these oligos were as follows: LacZ.R6I2: 7, 7, 6, 7; LacZ.R2.47I2: 
4, ND, 4, ND; LacZ.R1S1:7, 7, 7, 6; LacZ.R5S1: 6, 6, 6, 6; LacZ.D: 6, 6, 6, 6; LacZ.D.47: 
4, ND, 4, ND; no oligo: 10, 10, 10, 10. ND, not determined. The strains used were 










4.4.2. RNase HII cleavage of heteroduplexes containing paired or mispaired rNMPs 
The inability of the rnhB mutation to increase gene correction frequencies by the 
LacZ.R5S1 and the LacZ.R2.47I2 oligos and its capacity to increase gene correction by the 
LacZ.R6I2 oligo to a much lesser extent than by the LacZ.R1S1 oligo may be a reflection 
of the specificity of RNase HII. To test this hypothesis, we analyzed the ability of the 
purified enzyme to cleave heteroduplexes containing the same sequences and RNA/DNA 
mismatches that we examined in the transformation experiments (Table A.2 and Figure 
4.2a). RNase HII cleavage of these different substrates was determined by 
polyacrylamide gel electrophoresis (PAGE) following two-hour incubation at 37 
◦
C (see 
Methods section). Under these experimental conditions, substrates with a single rNMP 
mispair, whether alone or in a tract of 5 rNMPs (substrates S2 and S6, respectively), were 
cleaved to the same extent as the rNMP-containing substrates with no mismatches (S1 
and S5, respectively) (Figure 4.2a,b). RNase HII cleaved 5‟ to the last ribonucleotide, or 
the junction ribonucleotide, in the 5 and 6-ribonucleotide tracts. The faint bands 
appearing below the major cleavage band for each substrate containing more than 1 
rNMP are products of RNA degradation, as they appear also in the absence of RNase HII 
(Figure A.1). The substrate containing a loop of two unpaired rNMPs alone (S11) was 
not cleaved. The substrate containing the same rNMP loop within a stretch of 6 rNMPs 
was cleaved to a lesser extent (53 %) than those containing a single mispair (S2 and S6). 
These data, except those obtained with the S6 substrate, are entirely consistent with our in 
vivo results (Table 4.1), in which gene correction by LacZ.R2.47I2 or the LacZ.R6I2 oligo 
is significantly more efficient than correction by the LacZ.R1S1 oligo in the presence of 
RNase HII, and deletion of rnhB does not increase at all gene correction by the 
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LacZ.R2.47I2 oligo. When we performed a similar experiment in conditions in which 
RNase HII cleaved the substrate with a single rNMP mispair (S2) at 77 %, the substrate 
with the same mispair in a tract of 5 rNMPs (S6) was cleaved at 50 %, thus less 
efficiently than S2 though much more efficiently than S4 (5.4 %) and S11 (<1 %) 
(Figure 4.2c,d). Overall, the RNase HII cleavage results do not explain why in vivo the 
rnhB mutation did not increase gene correction by the LacZ.R5S1 oligo while it increased 
gene correction by the LacZ.R6I2 (Table 4.1). Therefore, in this case, there is no 
correlation between the preference for the substrate containing a single rNMP mispair in 


















Figure 4.2 RNase HII cleavage specificity. (a) Structural presentation of 5‟-radiolabeled 
(
32
P, indicated by a purple asterisk) substrates (S1-S11) and cleavage percentage for each 
substrate, expressed as median and range (in parentheses) from 3 independent samples. 
Inverted triangles indicate the cleavage sites. (b) Denaturing polyacrylamide gels 
showing fragments resulting from cleavage using RNase HII. M: 20/100 nt 
oligonucleotide marker. S1-S11: substrates used. (c) Substrates (S2, S4, S6, S11) used in 
the experiment shown in (d) and their cleavage percentage, expressed as mean and range 
(in parentheses) from 2 independent samples. (d) Denaturing polyacrylamide gel showing 
fragments resulting from cleavage using reduced amount of RNase HII and shorter 
incubation time. M: 20/100 nt oligonucleotide marker. S2, S4, S6, S11: substrates used. 
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4.4.3. Functional redundancy between mismatch repair and RNase H type 2 
functions in the removal of an rG/dT mispair in E. coli  
We next examined the capacity of the MMR system to recognize RNA/DNA mismatches 
in E. coli. The MMR system is highly conserved from prokaryotes to eukaryotes. It 
recognizes DNA/DNA mispairs, such as base-base mismatches as well as small insertions 
and deletions (ins/dels) occurring both during DNA replication [40] and recombination 
[131]. We modified the bacterial strain BW1947, containing just one missense mutation 
in lacZ (nucleotide 1384 G  A) [99], to generate a set of strains having wild-type and 
mutant alleles of mutS, rnhA and rnhB in all combinations (Table A.1a). We then 
transformed these strains with the LacZ.R1S1 (Figure 4.1b) or the LacZ.D control oligo. 
Transformation results are shown in Table 4.2. As expected, lacZ correction by the 
DNA-only oligo in mutS cells was several hundred-fold higher than in all mutS
+
 cells, in 
agreement with previous findings [99, 105]. MutS was also able to recognize the 
mismatched rG/dT mispair, as gene correction frequency by the LacZ.R1S1 oligo in mutS 
was 5-fold higher than in mutS
+
 cells. The relative transformation frequency of LacZ.R1S1 
increased only to 2-fold in the absence of RNase HI both in mutS
+
 and in mutS
 
cells, in 
line with the observation that RNase H type 1 cannot cleave at rNMPs in stretches of less 
than 4 [20, 23]. In mutS
+ 
cells an rnhB mutation enhanced the frequency of 
transformation by LacZ.R1S1 only 11-fold (21.8/1.88) (Table 4.2), as opposed to the 
6,800-fold enhancement seen in a mutS mutant (Table 4.1). The rnhB mutS double 
mutant showed correction frequency for the LacZ.R1S1 oligo 17,500-fold (33,000/1.88) 
higher than the wild type and 1,500-3,400-fold higher than either of the single mutants 
(Table 4.2). The gene correction frequency by LacZ.R1S1 increased 77,000-fold 
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(145,000/1.88) in the rnhA rnhB mutS triple mutant compared to the frequency in wild-
type cells, and became similar to that of the corresponding DNA-only oligo in the mutS 
backgrounds used (Table 4.2). Further purification of the LacZ.R1S1 oligo by PAGE 
produced no observable changes in gene correction frequencies (not shown).We excluded 
the possibility of DNA contamination in our LacZ.R1S1 oligo sample by demonstrating 
alkali lability (Table A.4a). These data prove not only that the E. coli MMR system can 
recognize and remove an rG/dT mismatch in DNA, but also that MutS and RNase HII act 

















       Table 4.2 Tolerance of an rG/dT mispair in E. coli  
 LacZ.R1S1  LacZ.R5S1  LacZ.D No oligo 

















WT 1.88 0.02 0.36 4*10
-3
 90.7 < 0.1 
 (0.82-5.97)  (0-0.48)  (38.5-177)  
rnhA 12.1 0.04 256 0.76 336 < 0.1 
 (8.75-23.2)  (176-803)  (162-485)  
rnhB 21.8 0.13 0.715 4.3*10
-3
 165 < 0.1 
 (20.8-26.1)  (0.62-0.89)  (140-242)  
rnhA rnhB 174 0.37 22,600 48.2 470 < 0.1 





 82,300 7.76 
 (14-19.6)  (5.48-14.2)  (50,000-104,950) (4.6-9.51) 




 93,908 32.1 
 (34.8-137)  (213-820)  (37,900-145,000) (10-57.6) 
rnhB mutS 33,000 0.27 5.23 10
-5
 124,200 3.77 
 (30,400-79,500)  (4.34-5.66)  (84,600-163,000) (3.51-5.06) 
rnhA rnhB mutS 145,000 0.69 22,400 0.11 212,000 24 




The strains used were BW2038A,B, YSB-21A,B, YSB-22A,B, and YSB-23A,B, which 
were mutS
+
 and BW2037A,B, YSB-19A,B, YSB-17,18, YSB-20A,B, which were mutS.  
b
The values are median and the range (in parenthesis) of E. coli Lac
+
 transformant 
colonies reverting the missense mutation per 10
7
 viable cells for each oligo. The numbers 
of repeats for each of the strains transformed with these oligos were 4. The significance 
of all non-overlapping confidence limit values was confirmed by the Mann-Whitney test 
(P < 0.05) (Table A.3b). 
c
The relative frequencies of Lac
+ 












4.4.4. Inefficient mismatch repair of an rC/dA mispair in E. coli 
We then investigated whether MMR could recognize an rC/dA mismatch. We used an 
oligo of the lagging strand containing an rC ribonucleotide (RpsL.R1S1) that would 
replace a dT in the rpsL wild-type gene of E. coli BW2037 and derivative strains (Table 
A.1a), generating the K87R mutation (rpsL40) that confers streptomycin resistance[99] 
(Figure 4.1c). We found that the dC/dA mismatch was efficiently repaired by the MMR 
system in E. coli, consistent with previous findings [132]. Whereas the ribonucleotide in 
the rC/dA mismatch in rpsL was removed very efficiently by RNase HII, there was only a 
modest, but still detectable, correction by MMR in rnhB cells (Table 4.3). These data 
differ from our results with an rG/dT mismatch in the lacZ gene, where MMR had a 
much stronger effect. We conclude that MMR can recognize an rC/dA mismatch, but 













Table 4.3 Strong effect of RNase HII and minor effect of MutS in preventing gene 
correction by an rC/dA mispair in E. coli 














WT 8 0.8 10 <0.1 
 (1.46-8.60)  (5.41-17.7) (0-0) 
rnhB 1,850 316 5.86 <0.1 
 (1,410-2,460)  (4.37-8.27) (0-0.03) 
mutS 11.6 0.001 10,500 0.76 
 (10.5-13.1)  (8,070-12,900) (0.03-2.70) 
rnhB mutS 4,310 0.826 5,220 0.32 
 (3,000-5,320)  (2,660-8,930) (0.13-2.39) 
 
a
The strains used were BW2038A,B, BW2040A,B, BW2037A,B and BW2039A,B. 
b
The frequency of streptomycin resistant transformant colonies per 10
7
 viable cells for 
wild-type, mutS, rnhB single mutant and rnhB mutS double mutant after transformation 
with RpsL.R1S1 or RpsL.D oligo is shown as median and 95% confidence limits (in 
parentheses), or alternatively range when number of repeats was <6. The numbers of 
repeats for each of the wt, rnhB, mutS, and rnhB mutS strains transformed with these 
oligos were as follows: RpsL.R1S1: 4, 4, 4, 4; RpsL.D:4, 6, 6, 4; no oligo: 4, 4, 4, 4. The 
significance of all non-overlapping CI or range values was confirmed by Mann-Whitney 
test (P < 0.05) after subtraction of the background values (Table A.3c). 
c
Relative frequency of Str
r










4.4.5. RNase HI, but not mismatch repair targets an RNA/DNA heteroduplex region 
containing an rG/dT mispair in E. coli  
To determine if the MMR system can recognize and target an rG/dT mispair when 
present in an RNA/DNA heteroduplex region, we compared transformation frequencies 
by LacZ.R5S1 with those by LacZ.R1S1 and LacZ.D (Figure 4.1b). The recipient strains 
were derivatives of BW1947, which contains only the missense mutation in lacZ 
(nucleotide 1384 G  A), with wild-type and mutant alleles of rnhA, rnhB and mutS in 
all combinations (Table A.1a). Both LacZ.R1S1 and LacZ.R5S1 oligos produce the same 
rG/dT mismatch in vivo. In LacZ.R5S1, the mismatched ribonucleotide is in a tract of 5 
ribonucleotides, whereas in LacZ.R1S1 it is isolated in DNA. Although the rnhA mutation 
greatly enhanced the relative transformation frequency by LacZ.R5S1 in both mutS
+ 
and 
mutS cells (190 and 500-fold, respectively), rnhB had little effect except in combination 
with rnhA (up to 60-fold increase over the relative transformation frequency obtained in 
the rnhA single mutant strains) (Table 4.2). Surprisingly, mutS had no effect on the 
transformation frequency by the LacZ.R5S1 oligo3, which is in stark contrast to results 
obtained with the LacZ.R1S1 oligo (Table 4.2). Therefore, RNase HI, rather than RNase 
HII or MMR, is largely responsible for removing an RNA tract with a mismatch, whereas 
RNase HII and MMR are mostly responsible for processing an isolated mismatched 
ribonucleotide. 
 
4.4.6. Mismatch repair of RNA/DNA mispairs in yeast cells 
To test if the MMR system could recognize RNA/DNA mismatches in eukaryotic cells, 
we created a yeast S. cerevisiae strain in which we inactivated the genomic TRP5 gene by 
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introducing a two-base deletion and one-base substitution to cause a frameshift and a 
nonsense mutation 15 bp apart (YS-301 and YS-303, Table A.1b). The combination of 
these two mutations reduced the spontaneous reversion of trp5 to the Trp
+
 phenotype to < 
10
-9
, allowing the detection of very low frequencies of gene correction despite the low 
efficiency of gene targeting in yeast [52, 62]. MMR was inactivated by deletion of 
MSH2, a yeast mutS homolog [40]. RNase H2 was inactivated by deleting the gene of the 
catalytic subunit, RNH201 [20]. Unlike the E. coli  recombination system [105], gene 
correction at the yeast trp5 locus displayed no strand bias (Figure A.2). All TRP5 oligos 
used here had a sequence corresponding to the TRP5 sense strand. Wild-type and mutant 
cells were then transformed with an oligo containing two rNMPs to repair the deletion 
and another rNMP to correct the nonsense mutation in trp5 (TRP5.R2_R1I2_S1) (Figure 
4.1d and Table A.2). A DNA-only oligo (TRP5.D) provided a reference. The results 
(Table 4.4a) were similar to those obtained in E. coli with the LacZ.R1S1 oligo (Table 
4.2). Gene correction in the rnh201 single mutant was only ~2.5-fold more than that in 
wild-type cells. As expected [58], the msh2 deletion enhanced gene correction by the 
DNA-only oligo TRP5.D. With the TRP5.R2_R1I2_S1 oligo, in which both the 2-base 
insertion and the substitution were rNMPs, we observed a 5-fold (3.71/0.72) increase in 
gene correction efficiency in the msh2 mutant and more than a 45-fold (33.8/0.72) 
increase in the rnh201msh2 double mutant, making the RNA-containing oligo as efficient 
as the corresponding DNA-only oligo. The alkali lability of the TRP5.R2_R1I2_S1 oligo 
indicated that the results were not due to its contamination with DNA-only oligo (Table 
A.4b). We concluded that the yeast MMR system also recognizes RNA/DNA 
 95 
mismatches and can act redundantly with RNase H2 to remove mispaired ribonucleotides 
embedded in DNA.  
 
To determine whether the RNA/DNA ins/del and the rG/dT mispairs could be 
independently recognized by the MMR system in yeast, we constructed strains carrying 
either the nonsense mutation or the 2-base deletion in trp5 and having msh2 and/or 
rnh201 mutant alleles. We transformed these strains with oligos containing either a 1-
rNMP substitution (TRP5.R1S1) or a 2-rNMP insertion (TRP5.R2I2) (Figure 4.1e,f and 
Table A.2), respectively. Transformation results revealed that the rG/dT mispair was 
recognized by MMR in yeast (Table A.5a). To determine the effect of MMR on the 2-
rNMP insertion we sequenced all the Trp
+
 transformant clones obtained in the experiment 
with the TRP5.R2I2 oligo in order to distinguish Trp
+
 clones targeted by the oligos 
(TRP5.R2I2 or the TRP5.D control) from Trp
+ 
revertant clones (Tables A.5b-d). 
Sequencing of Trp
+
 transformants revealed that the ins/del RNA/DNA mismatch was 












Table 4.4 Competition between mismatch repair and RNase H type 2 functions 
in the removal of RNA/DNA mispairs in yeast 
a 



















WT 0.72 (0.40-1.32) 0.30 2.39 (1.50-3.51) < 0.1 (0-0) <0.1 (0-0) 
msh2 3.71 (2.07-4.31) 0.12 31.6 (24.5-37.2) < 0.1 (0-0) ND ND 
rnh201 1.84
c
 (1.15-2.88) 0.67 2.76 (1.83-3.29) < 0.1 (0-0.03) ND ND 
rnh201 msh2 33.8 (26.3-35.6) 0.76 44.6 (32.9-48.8) < 0.1 (0-0.57)
d
 0.51 (0-1.36) 
 
     b 
  
 
      
 TRP5.R2I2 
 











WT 1.65 (0.58-2.50) 0.04 39.1 (35.9-43.6) < 0.1 (0-0) 
msh2 7.64 (4.96-9.82) 0.17 46.1 (24.3-76.8) < 0.1 (0-0) 
rnh201 9.64 (7.51-15.0) 0.35 27.7 (12.3-36.9) < 0.1 (0-0) 
rnh201 msh2 26.9 (20.5-35.3) 0.38 70.0 (63.3-86.9) < 0.1 (0-0) 
(a) Trp
+
 transformant frequencies for strains that contained both a two-base pair deletion and a 
nonsense mutation. (b) Trp
+
 transformant frequencies obtained by precise correction of a two-base 
deletion calculated by multiplying the number of Trp
+
 transformant colonies per 10
7
 viable cells 
(shown in Table A.5b) by the percentage of clones with precise correction of the “CG” deletion 
(pattern R in Table A.5c,d). Each value represents the median and range (in parentheses) for 10
7
 
viable cells, based on 8 (a) or 4 (b) experiments. The significance of all non-overlapping confidence 
limits or range values was confirmed by Mann-Whitney test (P < 0.05) after subtraction of the no-
oligo background values (Table A.3e and A.3h).  
a
A non-specific oligo, with no homology to the targeting locus, corresponding to LEU2.R1dw 
sequence (Table A.2), was used as additional negative control. 
b
Relative frequency of Trp
+ 
transformants (see Methods). 
c
The gene correction frequency value obtained in the rnh201 mutant cells was different from that 
obtained in the wild-type cells at the significance level 0.1 (P = 0.082).  
d
Out of 7 Trp
+
 revertant clones obtained after transformation with the no-oligo control in rnh201 msh2 






Previously, in experiments of DSB repair in yeast using oligos containing tracts of four 
ribonucleotides or longer, we showed that oligos containing the shortest RNA tracts were 
the most efficient at chromosomal gene modification [77]. Also an oligo containing a 2-
base loop within a 6-rNMP tract was 25 to 50-fold less efficient at gene correction than 
the corresponding DNA-only oligo in E. coli [67]. Contrary to expectations, it was then 
remarkable to find in the current work that gene correction by an oligo containing just a 
single rNMP is 40-fold less efficient than that obtained with an oligo containing 6 rNMPs 
and 2,000-fold less than that obtained with the corresponding DNA-only oligo in E. coli 
(Table 4.1). Here we show that the capacity of rNMPs embedded in DNA to directly 
transfer genetic information to the genome is not only affected by the length but also by 
the structure of the embedded RNA tracts, which can be targets of specific proteins and 
be removed before serving as templates for DNA synthesis.  
 
Initial analysis of gene correction frequencies in rnh mutants in E. coli revealed a wide 
variation among different rNMP-containing oligos (Table 4.1). Whereas deletion of rnhB 
had no effect on the gene correction frequency by the oligo containing 5 rNMPs with the 
mispaired rG (LacZ.R5S1) and instead it increased gene correction by the LacZ.R6I2 oligo 
8 fold (Table 4.1), RNase HII cleaved in vitro a corresponding substrate with the 5 
rNMPs and the mispaired rG more efficiently than the substrate containing 6 rNMPs with 
a 2-rNMP loop (Figure 4.2). In the gene correction assay, RNase HI is the key factor 
targeting the stretch of 5 rNMPs, while RNase HII targets this substrate mainly in the 
absence of RNase HI (Tables 4.1 and 4.2). In contrast, the tract of 6 rNMPs containing 
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the 2-rNMP loop of the LacZ.R6I2 oligo is not a good substrate for RNase HI or HII in E. 
coli. The presence of a 2-rNMP loop (generated by LacZ.R6I2 or LacZ.R2.47I2), but not 
that of a mispaired rNMP (generated by LacZ.R1S1, LacZ.R5S1 or rpsL.R1S1) probably 
hampers RNase HI and RNase HII cleavage activity in E. coli (Tables 4.1, 4.2 and 4.3). 
Interestingly, a 2-rNMP loop is targeted by RNase H2 in yeast (Table 4.4b), possibly due 
to the processive activity of this enzyme in eukaryotes [20]. While it is known that RNase 
H type 1 and type 2 have distinct cleavage specificities, mostly from biochemical studies 
[20, 23, 126], our in vivo gene correction results shed light on the in vivo substrate 
specificity of these enzymes and offer an opportunity to investigate the mechanism 
underlying cellular tolerance of ribonucleotides misincorporated into genomic DNA. 
 
In addition to demonstrations of ribonucleotide incorporation by DNA polymerases in 
vitro [117-121, 123], recent work from the Kunkel group provides indirect evidence that 
ribonucleotides are incorporated into yeast DNA by low-fidelity pol2-M644G) and wild-
type Pol alleles and can destabilize the yeast genome in rnh201 cells [111, 124], 
strengthening the knowledge that yeast rnh201 mutant cells display an increased rate of 
genome instability [133]. Up to a 25-fold increase in the rate of spontaneous mutagenesis 
was observed in cells with rnh201 null [111]. Interestingly, the frequency of base 
substitutions (G to A transitions) increased 6-fold in pol2-M644G rnh201 when the 
MMR gene MSH6 was also deleted [124]. MMR could recognize RNA/DNA mismatches 
generated by polymerase  and/or by other replicative polymerases [123]. Moreover, also 
repair polymerases, such as Pol , Pol and LigD polymerase can add rNMPs in DNA 
[120-122], and especially error-prone polymerases might be more promiscuous at rNMP 
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incorporation in DNA. We suggest that RNA/DNA mismatches can arise by mispairing 
of an rNMP during its incorporation, or by a correct pairing during initial incorporation 
followed by the mispairing of a dNMP during a subsequent round of DNA synthesis. In 
the current work, we have found that MMR can remove the region containing a mispaired 
rNMP. 
 
Among the types of RNA/DNA mismatches examined, we found that the rG/dT mispair 
is well recognized by the MMR system both in E. coli and in yeast cells. A preliminary 
binding experiment of yeast Msh2/Msh6 to an rG/dT mismatch [124] supports our 
finding that the MMR system can target this mismatch in vivo. The rC/dA mispair is also 
targeted by the MMR system in E. coli, although less efficiently, since gene correction by 
the oligo generating the rC/dA mispair is increased only a few fold in the absence of 
MutS in the rnhB mutant cells (Table 4.3). The sequence context surrounding the 
RNA/DNA mispair could certainly affect RNA/DNA mismatch recognition and/or 
removal. A more rigorous analysis of eukaryotic and prokaryotic MMR factor binding 
and ATPase functions in the context of various RNA/DNA mismatches will be an 
important next step to better characterize the capacity of MMR factors to process 
RNA/DNA mismatches. In yeast cells, gene correction by the TRP5.R2_R1I2_S1 and by 
the TRP5.R2I2 oligos was 5-fold and 4-fold more efficient in msh2 than in wild-type cells, 
respectively (Table 4.4). Thus, we conclude that the MMR system can target, with 
different specificity, RNA/DNA mismatches (in E. coli and yeast) or small 
insertions/deletions (in yeast, not tested in E. coli). Moreover, our work demonstrates not 
only that RNA/DNA mismatches are susceptible to MMR but also that MMR and RNase 
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H type 2 compete for RNA/DNA mismatches both in the E. coli and the yeast S. 
cerevisiae systems. Absence of both RNase H type 2 and MMR functions has a 
synergistic effect on gene correction frequency by the TRP5.R2_R1I2_S1 and the 
LacZ.R1S1 oligos (Table 4.4a and Table A.5a). 
 
The MMR system of E. coli can recognize RNA/DNA mismatches only when these 
consist of one or two isolated ribonucleotides embedded in DNA, but not when the 
RNA/DNA mismatch is within an RNA/DNA duplex region. Indeed, while the single 
rG/dT mispair was very efficiently removed by the MMR system, there was no detectable 
effect of MMR on the same rG/dT mispair in the same sequence context, when the 
mispair was surrounded by two rNMPs on each side (Figure 4.1b and Table 4.2). 
Differently from the misincorporated rNMPs scattered in DNA, which are preferred 
substrates for RNase H type 2 and are not targeted by RNase H type 1, mispairs in longer 
RNA-tracts, such as those that could be generated by error-prone primases that can 
misincorporate dNMPs, or those that could be present in RNA/DNA hybrid tracts of R-
loops, are primarily targets of RNase H type 1, which can only be partially backed up by 
RNase H type 2 function.  
 
In summary, we have demonstrated that the MMR system recognizes and targets several 
types of RNA/DNA mismatches present in DNA in E. coli and S. cerevisiae cells. In 
addition, an RNA/DNA heteroduplex region that contains a mismatch is preferentially 
and efficiently targeted by RNase H type 1 in vivo, whereas mispaired rNMPs in E. coli 
and yeast and small rNMP insertions in yeast are specific substrates for RNase H type 2. 
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Thus, RNase H type 2 and MMR have overlapping activity in contributing to the removal 
of mispaired rNMPs embedded in DNA both in a prokaryotic and a eukaryotic cell 
system. Our findings also open up the possibility that other DNA repair mechanisms 




























4.6. ACKNOWLEDGEMENTS  
The authors thank P. W. Doetsch with his group and Y. W. Kow for discussions and 
comments; we are grateful to G. F. Crouse and R. Pai for suggestions on the paper, C. 
Flood for technical assistance and all the members of the Storici laboratory for technical 
support and advices in the course of the study. This research was supported by the 
Georgia Cancer Coalition grant (R9028), the NSF MCB-1021763 grant and the 























RNA molecules have a variety of important or essential biological functions in cells. In 
addition to mRNA, rRNA and tRNA, which play central roles in protein synthesis, a 
number of regulatory non-coding RNAs are involved in regulation of transcription and 
translation [110]. As recently demonstrated in a model organism, the yeast S. cerevisiae, 
using synthetic RNA-containing oligos, RNA can serve as a direct template for DNA 
synthesis during DSB repair. This was the first proof that an RNA template can directly 
repair a DSB and transfer genetic information to DNA without being reverse transcribed 
into cDNA [77].  
 
In this study, we showed that the function of RNA as a template for DNA synthesis 
occurs not only in yeast but also in E. coli and in human HEK-293 cells. We excluded the 
possibility that RNA-driven repair and modification is mediated by a cDNA reverse 
transcript by showing that RNA-containing oligos display the same strand bias targeting 
as the corresponding DNA. These findings established that the capacity of RNA to 
directly transfer genetic information to DNA is conserved from a prokaryotic to a higher 
eukaryotic cell system. The direct flow of information from RNA to DNA suggests that 
RNA could guide genetic alterations and be a source of genetic variation. 
 
Following the demonstration that RNA can be used as template for DNA sysnthesis at the 
chromosomal level in different cell types, we directed our studies to determine which 
RNA sequences would be more prone to transfer information to genomic DNA in cells. 
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For this goal, we developed a procedure to generate desired RNA/DNA hybrids at the 
chromosomal level by transformation using RNA-containing oligos that have homology 
to a specific defective reporter gene located on chromosomal DNA. If the RNA tract of 
the RNA-containing oligos is used as template for DNA synthesis at the chromosomal 
level, the defective reporter gene is corrected providing for a detectable phenotype. The 
frequency of reporter gene correction reflects the frequency by which a specific RNA 
tract can transfer information to DNA. We started this procedure in yeast S. cereviae and 
then extended it to the bacterium E. coli. This procedure turned out very useful especially 
to analyze the effect of single rNMPs or short rNMP tracts embedded in DNA, which 
could be frequently occurring in genomic DNA. 
 
Recent studies have shown that rNMPs can be incorporated quite frequently into DNA by 
many different DNA polymerases that normally function during DNA replication and 
repair [25]. The misincorporated rNMPs could potentially also form base-base mispairs 
with the opposite dNMPs in a duplex DNA, and, if not removed, could serve as templates 
in the subsequent round of DNA synthesis and produce a genetic change. We postulated 
that the transfer of genetic information from RNA to DNA could be largely dependent on 
the stability of the RNA/DNA hybrids. Using our procedure to generate RNA/DNA 
hybrids in vivo, we have assessed factors that may affect the stability of RNA/DNA 
hybrids, such as sequence, length, structure, sequence context around the RNA tracts, and 
defects in RNases H and/or in DNA repair genes. We showed that isolated mispaired 
rNMPs in chromosomal DNA are recognized and removed not only by RNases H but 
also by the MMR system in both E. coli and yeast. Mispaired rNMPs in E. coli and yeast 
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and small rNMP insertions in yeast are specific substrates of RNase H type 2. A 
mismatch within an RNA/DNA heteroduplex region requires RNase H type 1 for 
efficient removal. Furthermore, in the absence of MMR and RNase H type 2, the RNA-
driven gene modification increased dramatically. Our results suggested that RNases H 
could be considered as DNA repair proteins in terms of their capacity to target 
misincorporated rNMPs in DNA. The MMR system and RNases H play a significant role 
in the maintenance of genome integrity.  
 
Overall, our results establish that the capacity of rNMPs to edit genomic DNA is 
conserved in three very distinct cell types, which are E. coli, S. cerevisiae and human 
cells, suggesting a more universal role of RNA in generating genetic variation and 
influencing DNA metabolism. Moreover, the finding that rNMPs are targets not only of 
RNases H but also of DNA repair factors, such as MMR factors both in a prokaryotic (E. 
coli) and a eukaryotic (S. cerevisiae) cell system, supports the fact that rNMPs are 
probably common non-standard nucleotides found in DNA. 
 
In the future, in addition to the rG/dT, rC/dA and 2-nt rGrC insertion loop mispairs tested 
in this study, we will design RNA-containing oligos to form other types of rNMP/dNMP 
mispairs or RNA insertion loops to characterize more substrates for MutS/Msh2 via both 
in vivo and in vitro experiments. We will perform the in vivo oligo-driven gene correction 
assays in both E. coli and yeast systems to compare the transformation frequencies in WT 
and mutS/msh2 mutant cells. We will generate various RNA/DNA mispair substrates by 
annealing RNA-containing oligos with their corresponding DNA oligos in vitro and test 
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the binding affinity of MutS/Msh2 to the RNA/DNA mismatch substrates. We will then 
compare results obtained with in vivo assays to those obtained with the in vitro assays for 
the same substrates. Other MMR factors, such as E. coli MutL, yeast Msh3, Msh6 and 
Mlh will also be tested both in vivo and in vitro to study their participation in the process 
of RNA/DNA mismatche repair. Besides the MMR system, other DNA repair pathways, 
like NER and BER will be studied to see if they are able to recognize and process 


















Our results demonstrated that RNA-containing oligos or RNA-only oligos can serve as a 
template for DNA repair and modification at the chromosomal level in prokaryotic E. coli 
and eukaryotic yeast S. cerevisiae and human cells. Remarkably, when oligos were used 
to repair a DSB in our yeast and human cell systems, RNA-only oligos were able to 
repair the break and transfer the genetic information to chromosomal DNA. Differently, 
RNA-only oligo-directed DNA modification was not observed in E. coli with the Lambda 
Red recombination system. In the DSB repair systems the RNA-only molecules can first 
serve as templates for repair synthesis and then can be discarded without being 
incorporated into the genome. Instead, in the Lambda Red recombination system, the 
oligos must first be incorporated into the genome and then they serve as templates for 
DNA synthesis in the next round of replication. It is possible that RNA-only oligos 
cannot be incorporated in the E. coli genome because there is no ligase to ligate a 5‟ 
ribonucleotide to 3‟ deoxyribonucleotide. Although, we believe that RNA-only molecules 
could also serve as templates for DNA synthesis at the chromosomal level in E. coli, if 
they were designed to repair a DSB in the genome, as we did in our yeast and human cell 
system. This newly discovered capability of RNA suggests that transcript RNAs, which 
are abundant in the nucleus of cells, have the potential to serve as a templates to repair a 
DSB occurring on the chromosomal DNA during or after transcription. Transcript RNAs 
could be ideal templates for homology-driven DSB repair, because the sequence of 
transcript RNAs directly derives from that of their coding DNAs. Nascent transcript 
RNAs still linked to their coding DNAs in the process of transcription could serve as 
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templates to correct DNA lesions, such as DSBs occurring on their own parental DNAs. 
We speculate that highly transcribed DNA genes that experience DSBs could be repaired 
more efficiently than poorly or non transcribed DNAs (Figure 6.1).  It is our future goal 
to set up an experimental system to detect transcript RNA-mediated DNA repair and 
modification in different organisms.  According to our previous results, the repair 
frequency by synthetic RNA-only oligos was extremely low [67, 77]. Therefore, in order 
to observe the rare repair events by transcript RNAs, we will choose highly transcribed 
genes as reporters and we will also employ a DSB system to stimulate the transfer of 
genetic information from the RNAs to chromosomal DNAs.   
 
 
Figure 6.1 Scheme of transcript RNA-mediated DSB repair 
 
Our results uncovered that the MMR system and RNases H can recognize and target the 
misincorporated rNMPs in DNA in E. coli and S. cerevisiae cells. Together with the 
conserved phenomenon of RNA-templated DNA repair and modification in both 
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prokaryotic and eukaryotic cell systems, the capacity of cells to maintain genome 
integrity by removing the misincorporated rNMPs is also conserved. Cells can use 
synthetic RNA-containing oligos for DNA synthesis and have evolved mechanisms to 
deal with rNMPs embedded in DNA, strengthening the hypothesis that rNMPs could be 
commonly present in the genome of cells. What are the biological functions of rNMPs 
incorporated in genomic DNA? Up to now there are only very few cases in which the 
presence of rNMPs in DNA is related to a specific biological function. The incorporation 
of one or two rNMPs was observed in the DNA duplex of the mat1 locus of the yeast 
Schizosaccharomyces pombe, suggesting that these rNMPs can play a role in the mating-
type switching in fission yeast [134, 135]. During bacterial nonhomologous end joining, 
rNMPs are efficiently added to DSB ends by the polymerase module of LigD enzyme, 
and then are resected until only a single 3‟-ribonucleotide remains, which facilitate nick 
sealing by ligase module of the LigD enzyme [136].  
 
It remains clearly understudied how the presence of rNMPs in genomic DNA alters DNA 
functions and how it affects genome integrity. There is indirect evidence that rNMPs 
incorporated into the yeast DNA by a low fidelity Pol  (pol M644G) can cause 2-5 bp 
deletions in repetitive sequences at a high rate in the absence of RNase H2 [25]. It was 
found that if rNMPs are present at cleavage sites of Topoisomerase I, Topoisomerase I 
cleavage at rNMPs leads to nicks in DNA which cannot be repaired properly by 
Topoisomerase I and result in accumulation of deletions within short tandem repeats 
[137]. These frameshift mutations lead to abnormal function of protein products, 
therefore, are harmful to cells. Our studies revealed that isolated rNMP are targets of the 
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MMR system and RNase H type 2 and that a tract of rNMPs is primarily targeted by 
RNase H type 1.  However, a 2-rNMP insertion loop cannot be recognized by RNase HII 
in E. coli and an rNMP mismatch embedded in an RNA/DNA hybrid cannot be 
recognized and removed by the MMR system. Our data suggest that the efficiency of 
rNMPs removal in DNA depends on the sequence, length, structure and sequence context 
of the rNMPs. The rNMPs that are not targeted by repair factors, can remain in the 
genome, thus could be mutagenic. 
 
Although rNMPs embedded in DNA can cause mutations leading to abnormal biological 
functions, they could, potentially, also be beneficial to cells by playing a role of signaling 
in DNA metabolism. Differently from the methyl-directed mechanism in E. coli, strand 
discontinuity is believed to serve as a signal that directs the targeting of MMR to the 
discontinuous strand in eukaryotes [30]. Discontinuity exists at the termini of Okazaki 
fragments of the newly synthesized lagging strand during DNA replication [30]. 
However, it still remains unclear what could be the signal for strand discrimination by the 
MMR on the leading strand. Since Pol , which is the leading strand polymerases [138], 
appears to incorporate about 10-fold more rNMPs in DNA than Pol  [5], it was 
hypothesized that rNMPs incorporated by Pol  after nicking by RNase H2 could serve as 
a signal for the recruitment of the MMR machinery to the leading strand.  
 
Ribonucleotides in DNA can cause the DNA backbone distortion and can become a 
hindrance of normal B form of DNA [112]. Therefore, rNMPs in DNA could affect the 
protein-DNA interaction. Transcription factors can bind to DNA motifs to activate or 
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repress gene expression [139]. If rNMPs are incorporated into the binding sites of 
transcription factors, they could pose a sequence or conformational change to prevent the 
correct binding with transcription factors, thus altering the gene expression.  
 
Our study demonstrated that the MMR pathway is involved in the removal of 
misincorporated rNMPs. There may be additional pathways for rNMP removal. The 
backbone distortion caused by the 2‟-OH group on the ribose ring of the rNMPs could be 
a target of NER enzymes, especially when a tract of rNMPs is incorporated.  Moreover, 
RNase H-dependent repair pathway for the removal of rNMPs embedded in DNA may 
involve FEN1 and PCNA, suggesting that rNMP repair could share common features 
with long-patch base excision repair [25].  Studying if other DNA repair pathways, such 
as NER and BER, are involved in rNMP removal can provide further insights to better 
understand the functions of rNMPs embedded in DNA and the significance of RNA-
















Figure A.1 Denaturing polyacrylamide gel showing fragments resulting from RNase HII 
cleavage and random RNA degradation in the absence of RNase HII. Structural presentation 
of the substrates is shown in Figure 4.2a. S3, the substrate that contains a stretch of 6 fully 
complementary ribonucleotides, was used to show fragments resulting from random RNA 
degradation without RNase HII. The position of the uncleaved 47-mers is shown to the left. The 
positions of the random cleavage of the S3 substrate in the absence of RNase HII are indicated by 
arrows to the right. These barely detectable degradation bands are similar to those seen for the 





Figure A.2 Strand-bias targeting effect of two complementary oligos, TRP5.72D and 
TRP5.72Dcom is mild in WT and cannot be observed in msh2 mutant strains. (a) Diagram 
and sequence of the chromosomal trp5 region targeted by the TRP5.72D and TRP5.72Dcom 
oligos. (b) Median and range of yeast Trp+ transformant colonies reverting the two-base deletion 
mutation per 107 viable wild-type or MMR mutant cells. The significance of all non-overlapping 
range values was confirmed by Mann-Whitney test (P < 0.05) after subtraction of the no oligo 
background values. Comparison of frequencies is presented in Table A.3d. The number of repeats 




























BW1892 mutS::gm cI857 (cro-bio) lacZ( GG1370-1; G1384→A) [130] 
BW1947 mutS:: gm cI857 (cro-bio) lacZ(G1384→A) [130] 
BW1947 (N-gam) BW1947 (N-gam) 
Transformation of 
BW1947 with an 
oligo[100] 
BW1988 BW1892 (N-gam)  
Transformation of 
BW1892 with an 
oligo[100] 
BW2028 BW1988 rnhA733::kan P1(JW0204-2)  BW1988 
BW2029 BW1988 rnhB782::kan P1(JW0178-1)  BW1988 
BW2031 BW1988 rnhB::FRT  
Excision of kan cassette 
from BW2029[140] 
BW2032 BW1988 rnhB::FRT rnhA733::kan P1(JW0204-2)  BW2031 
BW2037A,B mutS:: gm srlD3131::Tn10 cI857 (cro-bio) (N-gam) lacZ(G1384→A) 
P1(CAG18642) × BW1947 
(N-gam) 
BW2038A,B BW2037 mutS+ 
P1(CAG18642) × BW1947 
(N-gam) 
BW2039A,B BW2037 rnhB782::kan P1(JW0178-1) × BW2037 
BW2040A,B BW2037 mutS+ rnhB782::kan P1(JW0178-1) × BW2038
 
CAG18642 srlD3131::Tn10 [141, 142] 
JW0178-1 rnhB782::kan [143] 
JW0204-2 rnhA733::kan [143] 
YSB-13,14 BW1988 rnhA(48Oc,Op) 
Transformation of 
BW1988 with an oligo 
YSB-15,16 BW1988 rnhB(70Oc,Op) 
Transformation of 
BW1988 with an oligo 
YSB-17,18 BW2037 rnhB(70Oc,Op) 
Transformation of 
BW2037 with an oligo 
YSB-19A,B BW2037 rnhA(48Oc,Op) 
Transformation of 
BW2037 with an oligo 
YSB-20A,B BW2037 rnhA(48Oc,Op) rnhB(70Oc,Op) 
Transformation of YSB-18 
with an oligo 
YSB-21A,B YSB-19 mutS+ P1(JW2674-1) × YSB-19 
YSB-22A,B YSB-18 mutS+ P1(JW2674-1) × YSB-18 
YSB-23A,B YSB-20 mutS+ P1(JW2674-1) × YSB-20 
JW2674-1 srlD::(FRT-kan-FRT) [143] 
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b   
BY4742 MAT   his3 1 leu2 0 lys2 0 ura3 0 [52, 144] 
FRO-694 BY4742 trp5::GSKU  
Insertion of GSKU cassette 
into TRP5 
YS-301,303 BY4742 trp5( CC1001-2; G1017→A) 
Replacement of GSKU in 
FRO-694 with an oligo to 
introduce the desired 
mutations 
YS-305,306 YS-301,303 rnh201::kanMX4 
Disruption of RNH201 
with kanMX4 PCR product 
YS-307,308 YS-301,303 msh2::kanMX4 
Disruption of MSH2 with 
kanMX4 PCR product 
YS-313,314 YS-301,303 rnh201::hygMX4 msh2::kanMX4 
Disruption of RNH201 
with hygMX4 PCR product 
and of MSH2 with kanMX4 
PCR product 
YS-316,318 BY4742 trp5( CC1001-2) 
Replacement of GSKU in 
FRO-694 with an oligo to 
introduce the desired 
mutation 
YS-331,332 YS-316,318 rnh201::hygMX4 
Disruption of RNH201 
with hygMX4 PCR product 
YS-327,328 YS-316,318 msh2::kanMX4 
Disruption of MSH2 with 
kanMX4 PCR product 
YS-323,324 YS-316,318 rnh201::hygMX4 msh2::kanMX4 
Disruption of RNH201 
with hygMX4 PCR product 
and of MSH2 with kanMX4 
PCR product 
YS-320,322 BY4742 trp5(G1017→A) 
Replacement of GSKU in 
FRO-694 with an oligo to 
introduce the desired 
mutation
 
YS-333,334 YS-320,322 rnh201::hygMX4 
Disruption of RNH201 
with hygMX4 PCR product 
YS-329,330 YS-320,322 msh2::kanMX4 
Disruption of MSH2 with 
kanMX4 PCR product
 
YS-325,326 YS-320,322 rnh201::hygMX4 msh2::kanMX4 
Disruption of RNH201 
with hygMX4 PCR product 
and of MSH2 with kanMX4 
PCR product 
(a) E. coli strains.  (b) S. cerevisiae strains.  
a




. Abbreviations: gm, gentamycin resistance 
gene; kan, kanamycin resistance gene; FRT, Flp recombinase target sequence; GSKU, cassette 
containing the I-SceI endonuclease gene under the inducible GAL1 promoter, the kanMX4 
kanamycin resistance gene, the counterselectable KlURA3 marker and the I-SceI cutting site.  
b
Transductions with bacteriophage P1 are described as follows: P1(donor)  recipient. Selections 
were for resistance to kanamycin, tetracycline (Tn10), or gentamycin. 
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Table A.2 Oligos used in this study 
Name Size Structure from 5’ Sequence 
LacZ.R6I2 65 [D 22 R 2] ins::R 2 [R 2 D 10] sD1 [D 26] 5'-GTAATCACCCGAGTGTGATCATrCrUrGrGrUrCGCTGGGGAATGAGTCAGGCCACGGCGCTAATCACGAC 
LacZ.R1S1 65 [D 24] ins::D 2 [D 12] sR1 [D 26] 5'-GTAATCACCCGAGTGTGATCATCTGGTCGCTGGGGAATrGAGTCAGGCCACGGCGCTAATCACGAC 
LacZ.R5S1 65 [D 24] ins::D 2 [D 10 R 2] sR1 [R 2 D 24] 5'-GTAATCACCCGAGTGTGATCATCTGGTCGCTGGGGArArUrGrArGTCAGGCCACGGCGCTAATCACGAC 
LacZ.D 65 [D 24] ins::D 2 [D 12] sD1 [D 26] 5'-GTAATCACCCGAGTGTGATCATCTGGTCGCTGGGGAATGAGTCAGGCCACGGCGCTAATCACGAC 
RpsL.R1S1 70 [D 34] sR 1  [D 35] 5'- ACGTACGGTGTGGTAACGAACACCCGGGAGGTCTrCTAACACGACCGCCACGGATCAGGATCACGGAGTGC 
RpsL.D 70 [D 34] sD 1 [D 35] 5'- ACGTACGGTGTGGTAACGAACACCCGGGAGGTCTCTAACACGACCGCCACGGATCAGGATCACGGAGTGC 
TRP5.R2_R1I2_S1 65 [D 24] ins::R 2 [D 14] sR1 [D 24] 5'- AAAAGGGTTTTGATGAAGCTGTCGrCrGGATCCCACATTCTGrGGAAGACTTCAAATCCTTGTATTCT 
TRP5.D 65 [D 24] ins::D 2 [D 14] sD1 [D 24] 5'- AAAAGGGTTTTGATGAAGCTGTCGCGGATCCCACATTCTGGGAAGACTTCAAATCCTTGTATTCT 
TRP5.R1S1 65 [D 40] sR1 [D 24] 5'- AAAAGGGTTTTGATGAAGCTGTCGCCGATCCCACATTCTGrGGAAGACTTCAAATCCTTGTATTCT 
TRP5.R2I2 65 [D 24] ins::R 2 [D 39] 5'- AAAAGGGTTTTGATGAAGCTGTCGrCrGGATCCCACATTCTGGGAAGACTTCAAATCCTTGTATTCT 
TRP5.Dcc 65 [D 40] sD1 [D 24] 5'- AAAAGGGTTTTGATGAAGCTGTCGCCGATCCCACATTCTGGGAAGACTTCAAATCCTTGTATTCT 
TRP5.72D 72 [D 35] ins::D 2 [D 35] 5'-AAGAGAGTTGGAAAAGGGTTTTGATGAAGCTGTCGCGGATCCCACATTCTGGGAAGACTTCAAATCCTTGTA 
TRP5.72Dcom 72 [D 35] ins::D 2 [D 35] 5'-TACAAGGATTTGAAGTCTTCCCAGAATGTGGGATCCGCGACAGCTTCATCAAAACCCTTTTCCAACTCTCTT 
LEU2.R1dw 60 D 44 R1 D15 5’-TTAGGTGCTGTGGGTGGTCCTAAATGGGGATCCGGTAGTGTTAGrGCCTGAACAAGGTTTA 
LacZ.R1.47 47  5’-CCCGAGTGTGATCATCTGGTCGCTGGGGAATrGAGTCAGGCCACGGCG 
LacZ.R6.47 47  5’-CCCGAGTGTGATCATrCrUrGrGrUrCGCTGGGGAATGAGTCAGGCCACGGCG 
LacZ.R2.47I2 47 [D 17] ins::R 2 [D 28] 5’-CCCGAGTGTGATCATCTrGrGTCGCTGGGGAATGAGTCAGGCCACGGCG 
LacZ.R5.47 47  5’-CCCGAGTGTGATCATCTGGTCGCTGGGGArArUrGrArGTCAGGCCACGGCG 
LacZ.D.47 47 [D 17] ins::D 2 [D 28] 5’-CCCGAGTGTGATCATCTGGTCGCTGGGGAATGAGTCAGGCCACGGCG 
LacZ.comD.wt.47 47  5’-CGCCGTGGCCTGACTCATTCCCCAGCGACCAGATGATCACACTCGGG 
LacZ.comD.m1.47 47  5’-CGCCGTGGCCTGACTTATTCCCCAGCGACCAGATGATCACACTCGGG 
LacZ.comD.del2.45 45  5’-CGCCGTGGCCTGACTCATTCCCCAGCGAAGATGATCACACTCGGG 
In the name of the RNA-containing oligos, substitutions are indicated by a subscript capital “S” and insertions by a subscript capital “I”. The letters “S” and “I” are followed by a 
subscript number indicating the number of bases that are substituted or inserted, respectively. The structures of the oligos used in this study are described from the 5’end, with 
DNA sequences (D) shown in blue and RNA sequences (R) in red. Bases with homology to the chromosomal DNA are shown in brackets and underlined. Insertions are indicated 
as “ins::”. Base substitutions are indicated as “s”. In the oligo sequences, the base changes introduced by the oligos are in bold and shown in blue , if these consist of DNA bases 
and in red, with lower case “r” on the left side, if these consist of RNA bases. The RNA tracts of the non-specific LEU2.R1dw oligo and of the lacZ oligos used only in the RNase 
HII cleavage assay are shown in regular red type. The restriction sites that are introduced by the oligos are underlined (thin underline for Van91I, thick line for BamHI). The DNA 
oligos were desalted (synthesized by Invitrogen, Carlsbad, CA, or Alpha DNA, Montreal, Quebec, Canada); the RNA–containing oligos were desalted and deprotected (by 
Thermo Scientific Dharmacon, Lafayette, CO). The LacZ.R1S1 and all the lacZ 45- and 47-mers were also PAGE purified (by Thermo Scientific Dharmacon or by Invitrogen). 
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Table A.3 Statistical comparisons (P-values) between gene correction frequencies obtained 








mutS vs.  
mutS rnhA rnhB 
mutS rnhA vs.  





LacZ.R6I2 0.0960 0.0012 0.0021 0.0021 0.0034 
LacZ.R2.47I2 ND 0.6857 ND ND ND 
LacZ.R1S1 0.0032 0.0021 0.0034 0.0034 0.6166 
LacZ.R5S1 0.0050 0.7000 0.0022 0.0050 0.0022 
 
II) 
Oligo mutS mutS rnhA mutS rnhB mutS rnhA rnhB 
LacZ.R6I2 vs. LacZ.R2.47I2 0.0061 ND 0.7619 ND 
LacZ.R6I2 vs. LacZ.R1S1 0.0021 0.0021 0.0034 0.0034 
LacZ.R6I2 vs. LacZ.R5S1 0.0167 0.0214 0.0238 0.0034 
LacZ.R1S1 vs. LacZ.R5S1 0.0222 0.0218 0.0222 0.0022 
LacZ.R1S1 vs. LacZ.R2.47I2 0.0106 ND 0.0106 ND 
LacZ.R5S1 vs. LacZ.R2.47I2 0.0095 ND 0.0095 ND 
Mann-Whitney test was applied to determine whether a difference exists between various pairs of 
gene correction frequencies. (a) Comparison of frequencies presented in Table 4.1. Two groups 
in a pair were considered to be significantly different when P-values were less than 0.05.  I) 
Comparisons were between relative frequencies obtained for each oligo in different backgrounds, 
















LacZ.R1S1 0.0286 0.0286 0.0286 0.0286 0.0286 
LacZ.R5S1 0.0294 0.0294 0.0294 0.0286 0.0286 
LacZ.D 0.0571 0.1143 0.0286 0.3429 0.0286 







rnhA rnhB mutS 
rnhA mutS vs. 
rnhA rnhB mutS 
rnhB mutS vs. 
rnhA rnhB mutS 
LacZ.R1S1 0.0286 0.0286 0.0286 0.0286 0.2 
LacZ.R5S1 0.0286 0.6857 0.0286 0.0286 0.0286 
LacZ.D 1.0000 0.1143 0.1143 0.1143 0.2 






rnhB vs.  
rnhB mutS 
rnhA rnhB vs. rnhA 
rnhB mutS  
LacZ.R1S1 0.0286 0.0286 0.0286 0.0286  
LacZ.R5S1 1.0000 1.0000 0.3429 1.0000 
 
LacZ.D 0.0286 0.0286 0.0286 0.0286 
 
      
II) 
Oligo WT rnhA rnhB rnhA rnhB 
No oligo vs. LacZ.R1S1 0.0286 0.0286 0.0286 0.0286 
No oligo vs. LacZ.R5S1 1 0.0286 0.1143 0.0286 
(b) Comparison of frequencies presented in Table 4.2. Two groups in a pair were considered to be 
significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies obtained 




Oligo WT vs. rnhB 
WT vs. 
mutS 






RpsL.R1S1 0.029 0.029 0.029 0.029 0.029 
RpsL.D 0. 171 0.010 0.029 0.010 0. 038 
 
II) 
Oligo WT rnhB mutS rnhB mutS 
No oligo vs. RpsL.R1S1 0.021 0.027 0.029 0.029 
No oligo vs. RpsL.D 0.021 0.013 0.010 0.029 
RspL.R1S1 vs. RpsL.D 0.486 0.010 0.010 0.486 
(c) Comparison of frequencies presented in Table 4.3. Two groups in a pair were considered to 
be significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies 




Oligo WT vs. msh2 
TRP5.72D 0.029 
TRP5.72Dcomp 0.029 
No oligo 0.027 
 
II) 
Oligo WT msh2 
No oligo vs. TRP5.72D 0.027 0.029 
No oligo vs. TRP5.72Dcomp 0.027 0.029 
TRP5.72D vs. TRP5.72Dcomp 0.029 0.886 
(d) Comparison of frequencies presented in Figure A.2b. Two groups in a pair were 
considered to be significantly different when P-values were less than 0.05. I) Comparisons 
were between frequencies obtained for each oligo in different backgrounds, and II) between 






































TRP5.R2_R1I2_S2 0.008 0.082 0.001 0.001 0.001 
TRP5.D 0.001 0. 875 0.001 0.083 0.001 
Non-specific oligo ND ND 0.197 ND ND 
 
II) 
Oligo WT msh2 rnh201 rnh201 msh2 
No oligo vs.TRP5.R2_R1I2_S2 0.004 0.001 <0.001 0.001 
No oligo vs. TRP5.D 0.001 <0.001 <0.001 0.001 
TRP5.R2_R1I2_S2 vs. TRP5.D 0.023 0.002 0. 267 0.052 
No oligo vs. Non-specific oligo ND ND ND 0.814 
(e) Comparison of frequencies presented in Table 4.4a. Two groups in a pair were considered to 
be significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies 




Oligo WT vs. msh2 WT vs. rnh201 
WT vs.  
rnh201 msh2 
msh2 vs.  
rnh201 msh2 
rnh201 vs.  
rnh201 msh2 
TRP5.R1S1 0.057 0. 486 0.029 0. 114 0.029 
TRP5.Dcc 0.029 0. 486 0.029 0. 343 0.029 
 
II) 
Oligo WT msh2 rnh201 rnh201 msh2 
No oligo vs.TRP5.R1S1 0.028 0.029 0.028 0.029 
No oligo vs. TRP5.Dcc 0.029 0.029 0.029 0.029 
TRP5.R1S1 vs. TRP5.Dcc 0.307 0.029 0.029 1.000 
(f) Comparison of frequencies presented Table A.5a. Two groups in a pair were considered to be 
significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies 



















Oligo WT vs. msh2 WT vs. rnh201 
WT vs.  
rnh201 msh2 
msh2 vs.  
rnh201 msh2 
rnh201 vs.  
rnh201 msh2 
TRP5.R2I2 0. 114 0.029 0.029 0.029 0.029 
TRP5.D 0.029 0.057 0.029 0.2 0.029 
 
II) 
Oligo WT msh2 rnh201 rnh201 msh2 
No oligo vs.TRP5.R2I2 0.041 0.029 0.029 0.029 
No oligo vs. TRP5.D 0.029 0.029 0.029 0.029 
TRP5.R2I2 vs. TRP5.D 0.029 0.029 0.057 0.029 
(g) Comparison of frequencies presented in Table A.5b. Two groups in a pair were considered to 
be significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies 






Oligo WT vs. msh2 WT vs. rnh201 
WT vs.  
rnh201 msh2 
msh2 vs.  
rnh201 msh2 
rnh201 vs.  
rnh201 msh2 
TRP5.R2I2 0. 029 0.029 0.029 0.029 0.029 
TRP5.D 1 0.057 0.029 0.342 0.029 
 
II) 
Oligo WT msh2 rnh201 rnh201 msh2 
TRP5.R2I2 vs. TRP5.D 0.029 0.029 0.057 0.029 
(h) Comparison of frequencies presented in Table 4.4b. Two groups in a pair were considered to 
be significantly different when P-values were less than 0.05. I) Comparisons were between 
frequencies obtained for each oligo in different backgrounds, and II) between frequencies 












LacZ.R6I2 1 0.548 
LacZ.R1S1 0.109 0.647 
(i) Comparison of frequencies presented in Table A.6a. Two groups in a pair were considered to be 
significantly different when P-values were less than 0.05. Comparisons were between frequencies 






Oligo BW2039 vs. YSB-18 
LacZ.R1S1 0.710 
LacZ.D 0.111 
No oligo 0.114 
(j) Comparison of frequencies presented in Table A.6b. Two groups in a pair were considered to be 
significantly different when P-values were less than 0.05. Comparisons were between frequencies 















Table A.4 Alkali lability of RNA-containing oligos used in E. coli or yeast transformation 
assays 
a                     
Oligo  WT mutS rnhB rnhB mutS 
LacZ.R1S1 
w/o NaOH 
1.98 (1.98-2.96) 16.5 (15.0-18.1) 7.84 (3.72-7.84) 25,100 (21,600-29,300) 
LacZ.R6I2 
w/o NaOH 
ND  583  (394-772) ND  ND  
LacZ.R2.47I2 
w/o NaOH 
ND  821 (204-1,020) ND  ND  
LacZ.D 
w/o NaOH 
156 (131-186) 49,400 (7,840-50,200) 60.3 (51.3-81.4) 78,400 (53,500-100,900) 
LacZ.D.47 
w/o NaOH 
ND  1,990 (1,990-3,670) ND  ND  
LacZ.R1S1 
w/ NaOH 
0.25 (0-0.25) 10.5 (8.63-11.8) <0.1 (0-0.1) 91.2 (75.4-120) 
LacZ.R6I2 
w/ NaOH 
ND  0.62 (0.31-0.63) ND  ND  
LacZ.R2.47I2 
w/ NaOH 
ND  17.2 (8.01-17.4) ND  ND  
LacZ.D 
w/ NaOH 
98.8 (91.4-126) 36,900 (32,900-52,500) 29.2 (19.1-36.2) 47,800 (25,200-91,700) 
LacZ.D.47 
w/ NaOH 
ND  2,090 (1,940-2,140) ND  ND  
No oligo <0.1  9.41  <0.1  18.3 (13.3-23.4) 
No oligo 
(BW1988) 
ND  <0.1  ND  ND  
b                     
Oligo WT rnh201 msh2 
TRP5.R2_R1I2_S1 
w/o NaOH 
0.19 (0-0.373) 10.7 (8.46-13.2) 
TRP5.D 
w/o NaOH 
4.34 (3.05-5.22) 38.4 (37.2-42.3) 
TRP5.R2_R1I2_S1 
w/ NaOH 
<0.1 (0-0) 0.255 (0-0.510) 
TRP5.D 
w/ NaOH 
1.7 (1.11-3.44) 28.5 (28.0-33.8) 
No oligo <0.1 (0-0) <0.1 (0-0) 
c                     

















d                    













No oligo 2.58 (2.58-5.15) 
(a) Median and range (in parentheses) of E. coli Lac
+
 transformant colonies, per 10
7
 viable wild-
type, MMR and RNase H mutant cells, following treatment or no treatment with NaOH, obtained 
using LacZ.R1S1, LacZ.R6I2, LacZ.R2.47I2, LacZ.D or LacZ.D.47. The LacZ.5RS1 and RpsL.R1S1 
oligos were not tested by alkaline hydrolysis, since it was clear from data in Table 4.2 and Table 
4.3, respectively, that the RNA-containing oligo solutions were indeed containing RNA and were not 
contaminated by the corresponding DNA-only oligo solutions. (b) Median and range (in 
parentheses) of yeast Trp
+
 transformant colonies, per 10
7
 viable wild-type, RNase H and MMR 
mutant cells, following treatment or no treatment with NaOH, obtained to correct the two-base 
deletion and nonsense mutations, (c) only the nonsense mutation, or (d) only the two-base deletion 













Table A.5 Reversion frequency of a nonsense mutation or a two-base deletion in the yeast 
trp5 gene following transformation by rNMP-containing oligos in MMR and RNase H 
mutant cells 
a  
Oligo WT msh2 rnh201 rnh201 msh2 
TRP5.R1S1 9.01 (8.23-11.9) 31.4
a
 (20.6-43.7) 11.2 (9.23-12.6) 84.7 (35.1-130) 
TRP5.Dcc 7.79 (5.46-11.9) 56.4 (51.4-69.1) 7.52 (5.93-7.84) 78.6 (54.6-90.9) 
No oligo 0.68 (0-0.99) 10.7 (8.6-19.3) 0.68 (0.37-1.65) 14.8 (8.2-20.7) 
b 





















































































d                     
Oligo WT msh2 rnh201 rnh201 msh2 
No oligo R 0/3 R 0/14 R 0/4 R 0/18 
 A 1/3 A 10/14 A 2/4 A 11/18 
 C 1/3 D 3/14 B 1/4 C 2/18 
 D 1/3 E 1/14 C 1/4 E 5/18 
TRP5.R2I2 R 7/15 R 20/33 R 65/65 R 115/152 
 B 7/15 A 9/33   R1 1/152 
 H 1/15 B 1/33   R2 1/152 
   C 1/33   A 28/152 
   E 1/33   C 1/152 
   I 1/33   D 2/152 
       F 1/152 
       G 2/152 
       J 1/152 
TRP5.D R 28/28 R 15/17 R 30/30 R 24/29 
   A 2/17   A 5/29 
(a) Median and range (in parentheses) of Trp
+
 transformant colonies per 10
7
 viable wild-type, 
MMR and RNase H mutant cells, obtained to revert the nonsense mutation, or (b) the two-base 
deletion in trp5. The number of repeats for each of the strains transformed with these oligos was 
4. Results obtained for oligos TRP5.R1S1 and TRP5.R2I2 were not due to contamination with DNA 
oligos (Table A.4c,d). The significance of all non-overlapping CI or range values was confirmed 
by Mann-Whitney test (P < 0.05) after subtraction of the no oligo background values. 
Comparison of frequencies is presented in  
Tables A.3f and A.3g. In (b), the percentage of clones with precise correction of the “CG” 
deletion (pattern R in (c)) is shown in bold under the median. The median and these percentages 
were used to calculate the frequency of Trp
+
 transformant colonies with precise correction of the 
two-base deletion mutation presented in (Table 4.4b). 
(c) Sequence patterns of the TRP5 region in Trp
+
 colonies transformed with no oligo, TRP5.R2I2, 
or TRP5.D oligos. Differences from the chromosomal sequence are in bold. Chr, chromosomal 
sequence of trp5 with the 2-base deletion mutation; R, sequence of the TRP5 region targeted with 
oligo TRP5.R2I2 or TRP5.D, containing the “CG” insertion; R1, R2, the TRP5 region corrected by 
oligos presenting additional mutations; A-J, patterns of the TRP5 region from spontaneous Trp
+
 
revertants. (d) The frequency of each sequence pattern obtained in WT, msh2, rnh201 and rnh201 
msh2 colonies following sequence analysis of 408 Trp
+
 clones from the experiment shown in (b) 
above. These data were used to generate results presented in Table 4.4b. 
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a
The gene correction frequency value obtained in the msh2 mutant cells was different from that 
obtained in the wild-type cells at the significant level 0.1 (P = 0.057) after subtraction of the no-
oligo background value.  
b
The gene correction frequency value obtained in the msh2 mutant cells was not significantly 
different from that obtained in the wild-type cells (P = 0.114) after subtraction of the no-oligo 
background value. However, after sequencing all the Trp
+
 clones of this experiment, the 
frequency value of precise gene correction obtained in the msh2 mutant cells was significantly 



























Table A.6 Deletion and nonsense mutations of rnhA and rnhB genes similarly affect 
gene correction by oligos in the BW1988 and the BW2037 backgrounds 
a 






















rnhB (BW2029) 0.16 (0.08-0.19) 3.43 (1.74-3.87) 
 





LacZ. R1S1  LacZ.D No oligo 
Genotype Lac
+ 

















(a) The strains used are BW2028, YSB-13, 14, BW2029, and YSB-15, 16, all of which are mutS 
mutants. All the strains were transformed with the LacZ.R6I2, LacZ.R1S1, or LacZ.D oligo. The 
values are relative transformation frequencies (see Methods). The numbers of repeats for each of 
strains transformed with these oligos were as follows: LacZ.R6I2: 7,3,7,3; LacZ.R1S1:6,3,7,3; 
LacZ.D: 6,3,6,3. The significance of all non-overlapping confidence limit values was confirmed by 
the Mann-Whitney test (P < 0.05) (Table A.3i). (b) The strains used were BW2039 and YSB-18. 
The strains were transformed with LacZ.R1S1 and LacZ.D oligos. The values are median and the 
range (in parenthesis) of Lac
+
 transformant colonies reverting the missense mutation per 10
7
 cells. 
The numbers of repeats for each of the strains transformed with these oligos were 4. The 
significance of all non-overlapping confidence limit values was confirmed by the Mann-Whitney 
test (P < 0.05) (Table A.3j).  
a
Relative frequency of Lac
+ 
transformants (see Methods). In the absence of a transforming oligo, 
the number of Lac
+
 transformants per 10
7
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